Unnamed: 0,title,date,stock,sentiment
138360.0,Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During ERA-EDTA Virtual Congress,2020-06-10 08:46:00-04:00,BAX,positive
138361.0,Baxter International shares are trading higher after the company received CE marking and regulatory approval from Australia's TGA for its Evo IG Syringe Infusion System.,2020-05-20 10:53:00-04:00,BAX,positive
138362.0,"Baxter Reports Receives CE Marking, Australian Regulatory Approval For Evo IQ Syringe Infusion System",2020-05-20 09:04:00-04:00,BAX,positive
138363.0,Baxter Raises Qtr. Dividend From $0.22 To $0.24/Share,2020-05-05 08:45:00-04:00,BAX,neutral
138364.0,"UBS Maintains Buy on Baxter International, Raises Price Target to $103",2020-05-01 12:04:00-04:00,BAX,neutral
138365.0,"SVB Leerink Maintains Outperform on Baxter International, Raises Price Target to $105",2020-05-01 09:49:00-04:00,BAX,neutral
138366.0,"Credit Suisse Maintains Outperform on Baxter International, Raises Price Target to $99",2020-05-01 08:06:00-04:00,BAX,positive
138367.0,"KeyBanc Maintains Overweight on Baxter International, Raises Price Target to $98",2020-05-01 06:11:00-04:00,BAX,negative
138368.0,"Baxter International Q1 EPS $0.820 Beats $0.720 Estimate, Sales $2.800B Beat $2.750B Estimate",2020-04-30 07:19:00-04:00,BAX,neutral
138369.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,BAX,positive
138370.0,"Earnings Scheduled For April 30, 2020",2020-04-30 04:16:00-04:00,BAX,neutral
138371.0,"JP Morgan Maintains Overweight on Baxter International, Raises Price Target to $96",2020-04-28 10:43:00-04:00,BAX,neutral
138372.0,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead",2020-04-27 09:44:00-04:00,BAX,positive
138373.0,Baxter Obtains U.S. FDA Emergency Use Authorization For Oxiris Blood Purification Filter For COVID-19 Treatment,2020-04-23 14:33:00-04:00,BAX,negative
138374.0,"3 Stocks Ready To Break Out, According To Josh Brown",2020-04-22 17:57:00-04:00,BAX,positive
138375.0,"Baxter Reports Will Increase Product Supply, Distribution",2020-04-15 16:50:00-04:00,BAX,positive
138376.0,"Raymond James Maintains Outperform on Baxter International, Raises Price Target to $97",2020-04-13 08:44:00-04:00,BAX,neutral
138377.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,BAX,positive
138378.0,"Notable Insider Buys In The Past Week: Carvana, MGM And More",2020-04-04 15:44:00-04:00,BAX,neutral
138379.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,BAX,positive
138380.0,"Morgan Stanley Maintains Equal-Weight on Baxter International, Raises Price Target to $95",2020-03-27 08:44:00-04:00,BAX,neutral
138381.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,BAX,positive
138382.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,BAX,negative
138383.0,"Stifel Upgrades Baxter International to Buy, Raises Price Target to $95",2020-03-19 05:10:00-04:00,BAX,neutral
138384.0,"Deutsche Bank Maintains Buy on Baxter International, Lowers Price Target to $99",2020-03-18 09:08:00-04:00,BAX,negative
138385.0,"Credit Suisse Maintains Outperform on Baxter International, Lowers Price Target to $96",2020-03-18 08:06:00-04:00,BAX,positive
138386.0,"Raymond James Maintains Outperform on Baxter International, Lowers Price Target to $90",2020-03-18 07:27:00-04:00,BAX,negative
138387.0,"Citigroup Maintains Neutral on Baxter International, Lowers Price Target to $89",2020-03-18 06:43:00-04:00,BAX,negative
138388.0,"KeyBanc Upgrades Baxter International to Overweight, Announces $92 Price Target",2020-03-18 05:44:00-04:00,BAX,negative
138389.0,"Baxter Says Due To Material Weakness, Concluded Co Did Not Maintain Effective Internal Control Over Financial Reporting As Of Dec. 31, 2019",2020-03-17 07:24:00-04:00,BAX,negative
138390.0,"Baxter International Q1 EPS $(0.05) Down From $0.76 YoY, Sales $3.04B Beat $2.86B Estimate",2020-03-17 07:22:00-04:00,BAX,neutral
138391.0,"6 Stocks To Watch For March 17, 2020",2020-03-17 05:30:00-04:00,BAX,neutral
138392.0,"Earnings Scheduled For March 17, 2020",2020-03-17 04:23:00-04:00,BAX,neutral
138393.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,BAX,negative
138394.0,"The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review",2020-03-15 09:55:00-04:00,BAX,neutral
138395.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,BAX,negative
138396.0,"Credit Suisse Maintains Outperform on Baxter International, Raises Price Target to $98",2020-03-06 10:32:00-05:00,BAX,positive
138397.0,"Benzinga's Top Upgrades, Downgrades For March 5, 2020",2020-03-05 10:05:00-05:00,BAX,positive
138398.0,"Citigroup Initiates Coverage On Baxter International with Neutral Rating, Announces $94 Price Target",2020-03-05 04:56:00-05:00,BAX,neutral
138399.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,BAX,positive
138400.0,"Wells Fargo Maintains Overweight on Baxter International, Raises Price Target to $102",2020-02-14 08:21:00-05:00,BAX,negative
138401.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2020",2020-02-13 09:56:00-05:00,BAX,positive
138402.0,"Goldman Sachs Initiates Coverage On Baxter International with Buy Rating, Announces $104 Price Target",2020-02-13 07:34:00-05:00,BAX,neutral
138403.0,"Baxter, COSMED Report FDA 510(k) Clearance For Q-NRG+ Indirect Calorimetry Device",2020-02-12 08:12:00-05:00,BAX,neutral
138404.0,"CFRA Maintains Hold on Baxter International, Raises Price Target to $93",2020-02-06 13:13:00-05:00,BAX,neutral
138405.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-06 10:39:00-05:00,BAX,neutral
138406.0,"Earnings Scheduled For February 6, 2020",2020-02-06 04:30:00-05:00,BAX,neutral
138407.0,Baxter And Spectral Medical Announce Exclusive Distribution Agreement For Blood Filter In US And Canada,2020-02-04 07:03:00-05:00,BAX,positive
138408.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-21 10:11:00-05:00,BAX,neutral
138409.0,"Wells Fargo Maintains Overweight on Baxter International, Raises Price Target to $100",2020-01-16 07:55:00-05:00,BAX,negative
138410.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,BAX,positive
138411.0,Baxter International shares are trading higher after the company reported preliminary Q4 and FY20 net sales above estimates.,2020-01-13 14:51:00-05:00,BAX,positive
138412.0,Baxter Preliminary FY 2019 Net Sales $11.4B vs $11.27B Est; Q4 Net Sales $3B vs $2.86B Est,2020-01-12 17:09:00-05:00,BAX,neutral
138413.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2020",2020-01-02 10:42:00-05:00,BAX,positive
138414.0,"Evercore ISI Group Upgrades Baxter International to Outperform, Announces $94 Price Target",2020-01-02 07:14:00-05:00,BAX,neutral
138415.0,"JP Morgan Maintains Overweight on Baxter International, Raises Price Target to $94",2019-12-20 09:01:00-05:00,BAX,neutral
138416.0,"UPDATE: Morgan Stanley On Baxter Notes 'Combined with accounting overhang it may take time for management to establish momentum, but resolution of accounting issues may drive a short-term recovery in shares'",2019-12-17 13:32:00-05:00,BAX,positive
138417.0,"UPDATE: Morgan Stanley Downgrades Baxter To Equal-Weight, Lowers Target To $88 Notes 'Less upside to 2020 revenue and need to reinvest in quality to support capacity may put 20-21% LRP margin target at risk'",2019-12-17 13:32:00-05:00,BAX,neutral
138418.0,"Benzinga's Top Upgrades, Downgrades For December 17, 2019",2019-12-17 11:16:00-05:00,BAX,positive
138419.0,10 Biggest Price Target Changes For Tuesday,2019-12-17 08:47:00-05:00,BAX,neutral
138420.0,"Morgan Stanley Downgrades Baxter International to Equal-Weight, Lowers Price Target to $88",2019-12-17 06:27:00-05:00,BAX,negative
138421.0,Sanofi to Sell its Seprafilm Device to Baxter for $350M,2019-12-02 07:33:00-05:00,BAX,neutral
138422.0,Hearing Unconfirmed Chatter Sanofi Will Sell its Seprafilm Device to Baxter for $350M,2019-12-02 07:08:00-05:00,BAX,negative
138423.0,Baxter Receives NYSE Notice Regarding Delayed Form 10-Q Filing,2019-11-22 16:06:00-05:00,BAX,negative
138424.0,9 S&P 500 Stocks With The Most Insider Selling,2019-11-08 13:53:00-05:00,BAX,neutral
138425.0,"UBS Maintains Buy on Baxter International, Lowers Price Target to $95",2019-10-28 08:11:00-04:00,BAX,negative
138426.0,﻿Baxter International shares are trading lower on continued momentum after the company issued Q3 preliminary sales below analyst estimates.,2019-10-25 10:21:00-04:00,BAX,neutral
138427.0,21 Stocks Moving In Thursday's Mid-Day Session,2019-10-24 13:21:00-04:00,BAX,neutral
138428.0,Baxter International shares are trading lower after the company issued Q3 preliminary sales below analyst estimates.,2019-10-24 08:31:00-04:00,BAX,neutral
138429.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,BAX,neutral
138430.0,Baxter Sees Prelim. Q3 Sales $2.85B vs $2.86B Est.,2019-10-24 07:29:00-04:00,BAX,neutral
138431.0,"Baxter Reports Internal Investigation Of Misstatements In Previously-Reported Non-Operating Income Related To Forex Gains, Losses",2019-10-24 07:22:00-04:00,BAX,negative
138432.0,"Baxter Sees Q4 As-Reported Sales Growth 3-4%, 5% On Constant Currency Basis",2019-10-24 07:18:00-04:00,BAX,positive
138433.0,"Baxter International Q3 Adj. Operating Income $555M, Sales $2.85B Miss $2.86B Estimate",2019-10-24 07:18:00-04:00,BAX,negative
138434.0,"Earnings Scheduled For October 24, 2019",2019-10-24 04:05:00-04:00,BAX,neutral
138435.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,BAX,positive
138436.0,"Sanofi, Baxter Shares Volatile Over Last Few Mins. As Hearing Sanofi In Talks To Sell Seprafilm Products To Baxter",2019-10-16 14:15:00-04:00,BAX,positive
138437.0,Stocks That Hit 52-Week Highs On Friday,2019-09-06 12:23:00-04:00,BAX,neutral
138438.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,BAX,neutral
138439.0,"Baxter Reports Partnership With COSMED For Next-Gen Indirect Calorimetry Device, No Terms Disclosed",2019-08-15 08:51:00-04:00,BAX,negative
138440.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-13 10:28:00-04:00,BAX,neutral
138441.0,Stocks That Hit 52-Week Highs Of Monday,2019-08-12 10:31:00-04:00,BAX,neutral
138442.0,"Baxter Reports Health Canada Approved Prismax System, Integrated Thermax Blood Warmer; Highlights Launch Of Prismax In Canada",2019-08-12 09:26:00-04:00,BAX,positive
138443.0,"Credit Suisse Maintains Outperform on Baxter International, Raises Price Target to $95",2019-07-26 09:45:00-04:00,BAX,positive
138444.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,BAX,neutral
138445.0,Baxter International Raises FY2019 EPS Guidance from $3.27-3.35 to $3.34-3.4,2019-07-25 07:24:00-04:00,BAX,neutral
138446.0,"Baxter International Q2 EPS $0.89 Beats $0.81 Estimate, Sales $2.84B Beat $2.79B Estimate",2019-07-25 07:24:00-04:00,BAX,neutral
138447.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,BAX,negative
138448.0,"Earnings Scheduled For July 25, 2019",2019-07-25 04:36:00-04:00,BAX,neutral
138449.0,"Baxter Announces FDA Approval Of Myxredlin, The First And Only Ready-To-Use Insulin For IV Infusion",2019-07-22 09:07:00-04:00,BAX,positive
138450.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,BAX,neutral
138451.0,"Baxter Investors 'Know What They're Getting,' KeyBanc Says",2019-06-26 15:41:00-04:00,BAX,neutral
138452.0,8 Biggest Price Target Changes For Wednesday,2019-06-26 12:33:00-04:00,BAX,neutral
138453.0,"UPDATE: KeyBanc Initiates Coverage On Baxter With Sector Weight, Notes 'We do not see obvious new catalysts that would materially drive upside to its LT targets'",2019-06-26 11:57:00-04:00,BAX,neutral
138454.0,"Wells Fargo Maintains Outperform on Baxter International, Raises Price Target to $91",2019-06-26 07:41:00-04:00,BAX,positive
138455.0,KeyBanc Initiates Coverage On Baxter International with Sector Weight Rating,2019-06-26 06:12:00-04:00,BAX,neutral
138456.0,Baxter Raises Qtr. Dividend From $0.19 To $0.22/Share,2019-05-07 09:18:00-04:00,BAX,neutral
138457.0,"The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings",2019-04-25 07:58:00-04:00,BAX,neutral
138458.0,"Baxter International Sees Q2 EPS $0.80-$0.82 vs $0.82 Est., Sees FY19 Adj. EPS $3.27-$3.35 vs $3.28 Est.",2019-04-25 07:19:00-04:00,BAX,neutral
138459.0,"Baxter International Q1 EPS $0.76 Beats $0.68 Estimate, Sales $2.63B Beat $2.61B Estimate",2019-04-25 07:18:00-04:00,BAX,neutral
138460.0,"Earnings Scheduled For April 25, 2019",2019-04-25 04:26:00-04:00,BAX,neutral
138461.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,BAX,neutral
138462.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,BAX,negative
138463.0,"Barclays Maintains Equal-Weight on Baxter International, Raises Price Target to $75",2019-04-15 09:51:00-04:00,BAX,neutral
138464.0,Evercore ISI Group Downgrades Baxter International to In-Line,2019-04-08 07:13:00-04:00,BAX,neutral
138465.0,"Wells Fargo Maintains Outperform on Baxter International, Raises Price Target to $89",2019-04-03 09:50:00-04:00,BAX,positive
138466.0,"The Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead",2019-03-29 07:42:00-04:00,BAX,positive
138467.0,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO",2019-03-28 07:54:00-04:00,BAX,neutral
138468.0,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",2019-03-27 07:52:00-04:00,BAX,positive
138469.0,Baxter Highlights Launch Of Clinolipid Olive Oil-Based Lipid Emulsion In US Later In 2019,2019-03-26 16:45:00-04:00,BAX,neutral
138470.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,BAX,negative
138471.0,"Baxter, bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury",2019-03-19 04:12:00-04:00,BAX,neutral
138472.0,"Baxter Reports FDA Approval, Launch Of Ready-To-Use Cardivascular Medicine Eptifibatide",2019-03-06 08:00:00-05:00,BAX,positive
138473.0,"Morgan Stanley Maintains Overweight on Baxter International, Raises Price Target to $83",2019-03-05 08:06:00-05:00,BAX,negative
138474.0,"Third Point Dissolves Stakes in Netflix, Microsoft; Cuts Stake in PayPal, Merck, Visa, American Express, Baxter; Raises Stakes in Campbell Soup, Salesforce",2019-02-09 14:04:00-05:00,BAX,negative
138475.0,Premier's ProvideGX Is Collaborating With Baxter Healthcare Corporation To Make Additional Generic Drugs Available For Purchase Through Premier's Group Purchasing Organization,2019-02-05 09:11:00-05:00,BAX,neutral
138476.0,10 Biggest Price Target Changes For Friday,2019-02-01 09:41:00-05:00,BAX,neutral
138477.0,"Benzinga's Top Upgrades, Downgrades For February 1, 2019",2019-02-01 09:20:00-05:00,BAX,positive
138478.0,"A Peek Into The Markets: US Stock Futures Mixed, Jobs Report In Focus",2019-02-01 06:29:00-05:00,BAX,neutral
138479.0,"Barclays Upgrades Baxter International to Equal-Weight, Raises Price Target to $72",2019-02-01 06:23:00-05:00,BAX,neutral
138480.0,Baxter Sees FY19 Adj. EPS $3.22-$3.30 vs $3.27 Estimate,2019-01-31 07:15:00-05:00,BAX,neutral
138481.0,"Baxter International Q4 EPS $0.78 Beats $0.73 Estimate, Sales $2.8B Inline",2019-01-31 07:15:00-05:00,BAX,neutral
138482.0,"Earnings Scheduled For January 31, 2019",2019-01-31 04:01:00-05:00,BAX,neutral
138483.0,"Baxter International At JP Morgan Conference Says Has More Than 200 Product Launches, Including Geographical Expansion Planned In Next Five Years",2019-01-07 14:11:00-05:00,BAX,positive
138484.0,Baxter Starts US Clinical Trial for on-Demand Peritoneal Dialysis Solution System,2019-01-07 08:58:00-05:00,BAX,positive
138485.0,Morgan Stanley Finds A Few Reasons To Double Upgrade Baxter,2019-01-02 14:34:00-05:00,BAX,neutral
138486.0,10 Biggest Price Target Changes For Wednesday,2019-01-02 09:42:00-05:00,BAX,neutral
138487.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2019",2019-01-02 09:15:00-05:00,BAX,positive
138488.0,"Citigroup Upgrades Baxter International to Buy, Raises Price Target to $76",2019-01-02 07:59:00-05:00,BAX,neutral
138489.0,A Peek Into The Markets: US Stock Futures Tumble,2019-01-02 07:37:00-05:00,BAX,neutral
138490.0,"Morgan Stanley Upgrades Baxter International to Overweight, Raises Price Target to $77",2019-01-02 07:21:00-05:00,BAX,negative
138491.0,"Credit Suisse Initiates Coverage On Baxter International with Outperform Rating, Announces $77 Price Target",2018-12-18 07:13:00-05:00,BAX,positive
138492.0,Baxter Amended 13D Filing From Dan Loeb's Third Point Shows Cut Stake From ~36M To ~28M Shares,2018-12-04 17:16:00-05:00,BAX,neutral
138493.0,"Wells Fargo Maintains Outperform on Baxter International, Raises Price Target to $76",2018-12-04 09:16:00-05:00,BAX,positive
138494.0,"Stocks Trading Ex Dividend For Fri., Nov. 30, 2018",2018-11-30 10:22:00-05:00,BAX,neutral
138495.0,"Stocks That Will Be Trading Ex Dividend Fri., Nov. 30, 2018",2018-11-29 10:49:00-05:00,BAX,neutral
138496.0,Baxter International Option Alert: Dec 21 $68.5 Calls at the Bid: 3600 @ $0.6 vs 152 OI; Ref=$67.19,2018-11-28 10:53:00-05:00,BAX,positive
138497.0,"UBS Initiates Coverage On Baxter International with Buy Rating, Announces $80 Price Target",2018-11-28 07:55:00-05:00,BAX,neutral
138498.0,"Citigroup Maintains Neutral on Baxter International, Lowers Price Target to $69",2018-11-13 08:12:00-05:00,BAX,negative
138499.0,"RBC Capital Maintains Sector Perform on Baxter International, Lowers Price Target to $70",2018-11-08 09:42:00-05:00,BAX,negative
138500.0,"Morgan Stanley Maintains Underweight on Baxter International, Lowers Price Target to $66",2018-11-05 12:41:00-05:00,BAX,negative
138501.0,"Argus Upgrades Baxter International to Buy, Announces $70",2018-11-02 10:22:00-04:00,BAX,neutral
138502.0,"Wells Fargo Maintains Outperform on Baxter International, Lowers Price Target to $72",2018-11-01 12:06:00-04:00,BAX,positive
138503.0,"BMO Capital Maintains Outperform on Baxter International, Lowers Price Target to $76",2018-11-01 11:01:00-04:00,BAX,negative
138504.0,"Leerink Swann Maintains Outperform on Baxter International, Lowers Price Target to $77",2018-11-01 10:43:00-04:00,BAX,negative
138505.0,"Stocks Which Set New 52-Week Low Yesterday, October 31st",2018-11-01 10:37:00-04:00,BAX,negative
138506.0,"Baxter International shares down 10.4%; Despite strong earnings and in-line guidance, the company said it experienced slower-than-expected return to pre-Hurricane Maria purchasing levels and felt an impact from distributor destocking of certain products.",2018-10-31 13:01:00-04:00,BAX,positive
138507.0,Baxter Sees FY18 Adj. EPS $2.98-$3 vs $2.99 Estimate,2018-10-31 07:15:00-04:00,BAX,neutral
138508.0,"Baxter International Q3 EPS $0.80 Beats $0.74 Estimate, Sales $2.8B Beat $2.78B Estimate",2018-10-31 07:15:00-04:00,BAX,neutral
138509.0,"Earnings Scheduled For October 31, 2018",2018-10-31 04:06:00-04:00,BAX,neutral
138510.0,Baxter Receives CE Mark for PrisMax,2018-10-29 07:19:00-04:00,BAX,neutral
138511.0,"Barclays Initiates Coverage On Baxter International with Underweight Rating, Announces $73 Price Target",2018-10-16 07:09:00-04:00,BAX,neutral
138512.0,"Morgan Stanley Maintains Underweight on Baxter International, Raises Price Target to $75",2018-10-11 09:07:00-04:00,BAX,neutral
138513.0,Baxter And Mayo Clinic Announce Collaboration To Establish Renal Care Center In U.S.,2018-10-02 09:05:00-04:00,BAX,positive
138514.0,Baxter Highlights 'A retrospective study reports that cases with billed charges for Floseal in spine surgery were associated with 46 percent fewer blood transfusions and 38 percent lower blood-related complications...',2018-09-27 08:45:00-04:00,BAX,negative
138515.0,Baxter Reports FDA Clearance Of ALTAPORE Bioactive Bone Graft In Posterolateral Spine Surgery,2018-09-26 09:00:00-04:00,BAX,neutral
138516.0,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding",2018-09-21 08:51:00-04:00,BAX,negative
138517.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,BAX,neutral
138518.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,BAX,neutral
138519.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,BAX,neutral
138520.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,BAX,neutral
138521.0,"Stocks That Made New 52-Week Highs So Far Today Include: NiSource, Pfizer, United Continental, UDR, Kellogg, Arthur J. Gallagher, PerkinElmer, Paypal, Thermo Fisher, Honeywell, Visa, American Express, Nike, Intuit, Boston Scientific, Microsoft, and AMD",2018-09-13 11:43:00-04:00,BAX,positive
138522.0,Baxter Reports FDA Clearance For Actifuse Flow As New Bone Graft Substitute,2018-09-06 08:50:00-04:00,BAX,neutral
138523.0,"Stocks Trading Ex Dividend For Thurs., Aug. 30, 2018",2018-08-30 09:46:00-04:00,BAX,neutral
138524.0,"Stocks That Will Trading Ex Dividend Thursday, August 30th:",2018-08-29 09:55:00-04:00,BAX,neutral
138525.0,"Baxter Int'l. Filing Shows Registration For Mixed Securities Shelf Offering, No Size Disclosed",2018-08-23 16:51:00-04:00,BAX,neutral
138526.0,"Baxter Reports CE Mark, Regulatory Approval Of New Evo IQ Infusion System For UK, Ireland, Australia, New Zealand",2018-08-01 09:01:00-04:00,BAX,positive
138527.0,"JP Morgan Maintains Overweight on Baxter International, Raises Price Target to $85",2018-07-27 07:55:00-04:00,BAX,neutral
138528.0,"Stocks Which Set New 52-Week High Yesterday, July 25th",2018-07-26 11:00:00-04:00,BAX,neutral
138529.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,BAX,negative
138530.0,UPDATE: Baxter Raises FY18 Adj. EPS Outlook From $2.72-$2.8 To $2.94-$3 vs $2.89 Estimate,2018-07-26 07:22:00-04:00,BAX,neutral
138531.0,Baxter Raises Outlook:,2018-07-26 07:21:00-04:00,BAX,neutral
138532.0,"Baxter International Q2 EPS $0.77 Beats $0.71 Estimate, Sales $2.842B Beat $2.83B Estimate",2018-07-26 07:21:00-04:00,BAX,neutral
138533.0,"Earnings Scheduled For July 26, 2018",2018-07-26 04:20:00-04:00,BAX,neutral
138534.0,"Stocks That Made New 52-Week Highs Earlier Include: Adobe, S&P Global, Baxter, Salesforce, Microsoft, Biogen, Becton, Norfolk Southern, Target, IHS Markit, Tiffany, Eli Lilly, Thermo Fisher, Facebook, FLIR Systems, Medtronic, and Mastercard",2018-07-25 12:25:00-04:00,BAX,neutral
138535.0,"Stocks Which Set New 52-Week High Yesterday, July 24th:",2018-07-25 12:14:00-04:00,BAX,neutral
138536.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,BAX,positive
138537.0,"Stocks That Made New 52-Week Highs Earlier Today Include: Tiffany, Visa, SunTrust, Baxter, Medtronics, Intuit, Costco, IHS Markit, Target, VeriSign, Salesforce, Norfolk Southern, Verisk, Facebook, Paypal, and Microsoft",2018-07-24 12:15:00-04:00,BAX,neutral
138538.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-07-22 17:03:00-04:00,BAX,neutral
138539.0,"UPDATE: Baxter Says It's Evaluating Other Potential Locations Including Contract Manufacturing Locations, Co. Expects Regulatory Meeting With FDA To Occur in 2018",2018-07-17 11:47:00-04:00,BAX,neutral
138540.0,"Baxter Intl. Says On July 17th, The FDA Released A Warning Letter Regarding A 2017 Inspection Of The Co.'s Newly Acquired Facilities In Ahmedabad, Warning Letter Doesn't Cause Co. To Change Its Long Range Financial Guidance Issued In May 2018 At This Time",2018-07-17 11:45:00-04:00,BAX,negative
138541.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,BAX,negative
138542.0,"Stocks That Made New 52-Week Highs Today Include: Adobe, Intuitive Surgical, Global Payments, Republic Services, Baxter International, Costco, Kohl's, Expeditors International, Centene, TJX Companies, Tiffany, Illumina, Salesforce, WW Grainger, and ONEOK",2018-06-12 14:52:00-04:00,BAX,neutral
138543.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,BAX,positive
138544.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,BAX,neutral
138545.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",2018-06-05 08:05:00-04:00,BAX,positive
138546.0,"Stocks That Made New 52-Week Highs Today: Salesforce, Microchip, Fiserv, Edwards Lifesciences, Nike, Stryker, Align Tech, NVIDIA, Visa, IDEXX Labs, Ralph Lauren, Extra Space Storage, Kohl's, Macy's, Marathon Petroleum, Baxter, Expeditors Int'l & TransDigm",2018-06-04 16:47:00-04:00,BAX,neutral
138547.0,"Baxter Highlights 9 New Abstract Presentations Will Be Given At ERA-EDTA Congress; Data Will Indicate HDx Is Superior To Standard High-Flux HD In Removal Of Middle, Larger Middle Molecules",2018-05-30 17:01:00-04:00,BAX,positive
138548.0,"Stocks That Made New 52-Week Highs Today Include: JB Hunt Transport, Nasdaq, Baxter International, Expeditors International, Centene, AES, Netflix, Intuit, Sysco, and Lab Corp",2018-05-25 10:34:00-04:00,BAX,neutral
138549.0,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",2018-05-25 09:19:00-04:00,BAX,negative
138550.0,"The Week Ahead: Target, Best Buy Help Close Out Earnings Season",2018-05-21 14:08:00-04:00,BAX,positive
138551.0,Baxter International Sees FY2023 EPS $4.90-5.05,2018-05-21 08:03:00-04:00,BAX,neutral
138552.0,Baxter International Raises FY2020 EPS Guidance from $3.25-3.40 to $3.60-3.75,2018-05-21 08:03:00-04:00,BAX,neutral
138553.0,Baxter International Holding Investor Conference Today,2018-05-21 07:05:00-04:00,BAX,neutral
138554.0,Baxter Reports FDA Clearance For New Spectrum IQ Infusion System,2018-05-14 08:36:00-04:00,BAX,neutral
138555.0,Baxter Increases Qtr. Dividend From 40.16 To $0.19/Share,2018-05-08 09:04:00-04:00,BAX,neutral
138556.0,Companies Holding Annual Shareholder Meetings Today Include: Baxter and Gannett,2018-05-08 07:05:00-04:00,BAX,neutral
138557.0,"The Week Ahead: Nvidia And Dropbox Earnings, April Retail Sales, Trump Drug Pricing Speech Expected",2018-05-07 08:01:00-04:00,BAX,neutral
138558.0,A Magnificent Multifactor Idea,2018-04-09 09:21:00-04:00,BAX,positive
138559.0,"CHF Solutions Announces New Distribution Agreement With Dimedix Surgical To Distribute Co.'s Aquadex FelxFlow System In Spain, Terms Not Disclosed",2018-04-05 08:32:00-04:00,BAX,positive
138560.0,"Citigroup Maintains Neutral on Baxter International, Raises Price Target to $70.00",2018-02-06 08:30:00-05:00,BAX,neutral
138561.0,Baxter Sees Q1 EPS $0.60-$0.62 vs $0.63 Est.; Sees FY18 EPS $2.72-$2.80 vs $2.72 Est.,2018-02-01 07:16:00-05:00,BAX,neutral
138562.0,"Baxter Reports Q4 Adj. EPS $0.64 vs $0.59 Est., Sales $2.8B vs $2.77B Est.",2018-02-01 07:15:00-05:00,BAX,neutral
138563.0,"Earnings Scheduled For February 1, 2018",2018-02-01 04:39:00-05:00,BAX,neutral
138564.0,Baxter Announces US FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin,2018-01-22 08:36:00-05:00,BAX,positive
138565.0,"JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",2018-01-08 09:00:00-05:00,BAX,positive
138566.0,"UPDATE: Mallinckrodt, Baxter Deal For RECOTHROM, PREVELEAK Will Include Upfront Payment Of $153M",2018-01-08 07:46:00-05:00,BAX,neutral
138567.0,"Mallinckrodt Reports Will Sell RECOTHROM, PREVELEAK To Baxter For ~$185M",2018-01-08 07:45:00-05:00,BAX,neutral
138568.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2018",2018-01-03 09:14:00-05:00,BAX,positive
138569.0,"Evercore ISI Group Initiates Coverage On Baxter International with Outperform Rating, Announces $71.00 Price Target",2018-01-03 08:13:00-05:00,BAX,neutral
138570.0,Raymond James Upgrades Baxter International to Outperform,2018-01-03 07:41:00-05:00,BAX,neutral
138571.0,JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans,2018-01-02 15:45:00-05:00,BAX,neutral
138572.0,"These 12 Stocks Struck All-Time Highs In 2017, But Analysts Still See Upside",2018-01-02 15:36:00-05:00,BAX,negative
138573.0,Bank of America Upgrades Baxter International to Buy,2018-01-02 08:59:00-05:00,BAX,neutral
138574.0,JP Morgan Upgrades Baxter International to Overweight,2018-01-02 06:17:00-05:00,BAX,neutral
138575.0,Baxter Highlights New Data Showing HDx Enabled By THERANOVA Removed Mid-Sized Uremic Toxins During Dialysis,2017-11-06 08:41:00-05:00,BAX,neutral
138576.0,"Baxter Raises FY17 Adj. EPS $2.40-$2.43 vs $2.39 Est., Q3 EPS Raised From $0.56-0.59 vs $0.60 Est.",2017-10-25 07:19:00-04:00,BAX,neutral
138577.0,"Baxter Reports Q3 Adj. EPS $0.64 vs $0.59 Est., Sales $2.7B vs $2.66B Est.",2017-10-25 07:18:00-04:00,BAX,neutral
138578.0,"Earnings Scheduled For October 25, 2017",2017-10-25 04:24:00-04:00,BAX,neutral
138579.0,"Baxter Says Expecting Reduction In Sales For Q4 Due To Hurricane Maria, But 'expects to mitigate the related earnings impact through positive performance in other areas of the business'",2017-10-12 16:16:00-04:00,BAX,positive
138580.0,"Baxter Reports Enrollment Of First Patient In US, Colombia Trials For HDx Therapy enabled By THERANOVA",2017-10-03 08:34:00-04:00,BAX,neutral
138581.0,UPDATE: Baxter Says Findings From Study 'do not demonstrate a significant improvement in any of the clinical outcomes assessed for patients who received fish oil containing intravenous lipid emulsions',2017-09-18 08:35:00-04:00,BAX,negative
138582.0,Baxter Reports Largest Qualitative Review Of 34 Global Studies About Efficacy Of Different Lipid Emulsions For Parenteral Nutrition,2017-09-18 08:34:00-04:00,BAX,neutral
138583.0,"Benzinga's Top Upgrades, Downgrades For August 17, 2017",2017-08-17 09:34:00-04:00,BAX,positive
138584.0,"Citigroup Initiates Coverage On Baxter International with Neutral Rating, Announces $63.00 Price Target",2017-08-17 07:47:00-04:00,BAX,neutral
138585.0,"Lightning Round: Jim Cramer Gives His Opinion On Blue Apron, Philip Morris And More",2017-08-08 06:57:00-04:00,BAX,neutral
138586.0,"Highlights From Third Point's Q2 Investor Letter: Baxter, Alibaba and BlackRock",2017-07-26 12:41:00-04:00,BAX,neutral
138587.0,"Third Point Investor Letter Says Baxter Can Combine Operational Efficiency With An Unlevered Balance Sheet To Drive Cont. Earnings Growth, Even Absent Any Multiple Expansion",2017-07-26 11:08:00-04:00,BAX,positive
138588.0,Baxter Raises FY20 Adj. EPS Outlook From $2.75-$3 To $3.25-$3.40,2017-07-26 07:17:00-04:00,BAX,neutral
138589.0,UPDATE: Baxter Raises FY17 Adj. EPS From $2.20-$2.28 To $2.34-$2.40 vs $2.27 Est.,2017-07-26 07:17:00-04:00,BAX,neutral
138590.0,Baxter Raises FY17 Outlook,2017-07-26 07:16:00-04:00,BAX,neutral
138591.0,"Baxter Int'l Reports Q2 Adj. EPS $0.63 vs $0.57 Est., Sales $2.6B vs $2.6B Est.",2017-07-26 07:16:00-04:00,BAX,neutral
138592.0,"Earnings Scheduled For July 26, 2017",2017-07-26 04:22:00-04:00,BAX,neutral
138593.0,"Benzinga's Top Upgrades, Downgrades For July 11, 2017",2017-07-11 09:27:00-04:00,BAX,positive
138594.0,BMO Capital Upgrades Baxter International to Outperform,2017-07-11 06:56:00-04:00,BAX,neutral
138595.0,"Cantor Fitzgerald Initiates Coverage On Baxter International with Overweight Rating, Announces $70.00 Price Target",2017-06-30 06:25:00-04:00,BAX,negative
138596.0,How Altimmune Is Trying To Get Ahead Of A Potentially Fatal 'Flu Pandemic',2017-06-23 08:15:00-04:00,BAX,negative
138599.0,Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline,2017-06-14 08:30:00-04:00,BAX,positive
138602.0,"Baxter Reports U.S. FDA Approval, Commercial Launch of Ready-to-Use Clindamycin Injection in Saline",2017-06-07 11:00:00-04:00,BAX,positive
138603.0,Baxter Highlights New Data on Novel HDx Therapy Enabled by THERANOVA Dialyzer: Showed Removal Performance Comparable to HDF Therapy,2017-06-05 08:20:00-04:00,BAX,positive
138604.0,Amended 13G Filing from Dan Loeb's Third Point Shows Reduced Stake in Baxter to 7.5% Stake,2017-06-02 17:10:00-04:00,BAX,neutral
138605.0,Baxter Reports 5-Year Deal with Mayo Clinic for Launching of R&D Collaboration to Transform Patient Care,2017-05-31 09:15:00-04:00,BAX,positive
138606.0,"Goldman Sachs Initiates Coverage On Baxter International with Buy Rating, Announces $71.00 Price Target",2017-05-16 07:20:00-04:00,BAX,neutral
138607.0,"Starboard Value 13F Out, Raises Stake in Baxter, Cognizant",2017-05-12 16:33:00-04:00,BAX,positive
138608.0,Baxter Receives Guidance From FDA Clarifying Regulatory Pathway For PD Solution System For Home Dialysis,2017-05-03 08:36:00-04:00,BAX,positive
138609.0,Baxter Increases Qtr. Dividend From $0.13 To $0.16/Share,2017-05-02 08:32:00-04:00,BAX,neutral
138610.0,Baxter Sees Q2 EPS $0.55-$0.57 vs $0.52 Est.,2017-04-26 07:17:00-04:00,BAX,neutral
138611.0,UPDATE: Baxter Raises FY17 Adj. EPS from $2.10-$2.18 to $2.20-$2.28 vs $2.17 Est.,2017-04-26 07:17:00-04:00,BAX,neutral
138612.0,Baxter Raises FY17 Outlook,2017-04-26 07:16:00-04:00,BAX,neutral
138613.0,"Baxter Reports Q1 Adj. EPS $0.58 vs $0.52 Est., Sales $2.5B vs $2.43B Est.",2017-04-26 07:16:00-04:00,BAX,neutral
138614.0,"Earnings Scheduled For April 26, 2017",2017-04-26 04:51:00-04:00,BAX,neutral
138615.0,20 Stocks Moving In Monday's Pre-Market Session,2017-04-17 08:24:00-04:00,BAX,neutral
138616.0,"Baxter Says Employee Receives DoJ Grand Jury Subpoena Pursuant to Criminal Investigation, Co Cooperating with DoJ",2017-04-14 08:57:00-04:00,BAX,negative
138617.0,BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause',2017-03-14 12:08:00-04:00,BAX,neutral
138618.0,"Third Point Out With Amended 13D Filing, Sells 5.9M Shares In Block Trade, Now Has Active 8.5% Stake",2017-03-01 11:33:00-05:00,BAX,positive
138619.0,"Baxter, Scinopharm Report Exclusive Partnership For Generic Oncology Injectables",2017-02-28 08:15:00-05:00,BAX,positive
138620.0,Baxter Sees Q1 Adj. EPS $0.50-$0.52 vs $0.44 Est.; FY17 Adj. EPS $2.10-$2.18 vs $2.11 Est.,2017-02-01 07:14:00-05:00,BAX,neutral
138621.0,"Baxter Reports Q4 Adj. EPS $0.57 vs $0.52 Est., Sales $2.6B vs $2.64B Est.",2017-02-01 07:13:00-05:00,BAX,neutral
138622.0,"Earnings Scheduled For February 1, 2017",2017-02-01 04:09:00-05:00,BAX,neutral
138623.0,Q4 2016 Real-Time Call Brief,2017-01-31 19:00:00-05:00,BAX,neutral
138624.0,Baxter to Expand Portfolio of Essential Generic Injectable Medicines with Acquisition of Claris Injectables Limited For $625M,2016-12-15 08:17:00-05:00,BAX,positive
138625.0,"10 Notable Stocks Trading Ex-Dividend Wednesday, November 30",2016-11-29 11:40:00-05:00,BAX,neutral
138626.0,Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy,2016-11-22 08:06:00-05:00,BAX,neutral
138627.0,"Baxter Adds $1.5B To Buyback Plan, Now Has ~$1.9B Under Amended Plan",2016-11-08 08:51:00-05:00,BAX,neutral
138628.0,Stocks Hitting 52-Week Highs,2016-10-25 10:24:00-04:00,BAX,neutral
138629.0,Baxter Raises FY16 GAAP EPS from Continuing Operations from $1.69-$1.74 to $1.88-$1.91,2016-10-25 07:06:00-04:00,BAX,neutral
138630.0,"Baxter Reports Q3 Adj. EPS $0.56 vs $0.45 Est., Sales $2.6B vs $2.55B Est.",2016-10-25 07:06:00-04:00,BAX,neutral
138631.0,"Earnings Scheduled For October 25, 2016",2016-10-25 04:15:00-04:00,BAX,neutral
138632.0,Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments,2016-10-24 08:08:00-04:00,BAX,neutral
138633.0,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",2016-10-19 12:38:00-04:00,BAX,negative
138634.0,Wells Fargo Earlier Initiated Coverage On Baxter International Inc. at Outperform,2016-10-13 11:34:00-04:00,BAX,positive
138635.0,"Barclays Bullish On Baxter International, $52 Price Target",2016-09-15 10:54:00-04:00,BAX,neutral
138636.0,Benzinga's Top Initiations,2016-09-15 09:36:00-04:00,BAX,positive
138637.0,"Barclays Initiates Coverage on Baxter International at Overweight, Announces $52.00 PT",2016-09-15 04:19:00-04:00,BAX,negative
138638.0,Baxter Shares Present Little Upside In Argus' View,2016-08-15 10:03:00-04:00,BAX,positive
138639.0,13F from Loeb's Third Point Shows Slightly Reduced Stake in Baxter,2016-08-12 16:21:00-04:00,BAX,neutral
138640.0,"Sunshine Heart Acquires Aquadex Product Line from Baxter form $4M in Cash, 1M Shares of SSH Common Stock",2016-08-08 05:32:00-04:00,BAX,positive
138641.0,Baxter Reports New Evidence Showing REVACLEAR Dialyzer Associated with Lower Drug Use During Hemodialysis,2016-07-27 08:35:00-04:00,BAX,negative
138642.0,"Third Point Investor Letter from Dan Loeb Shows Liquidated Stake in Amgen, Continued Stakes in Allergan, Baxter",2016-07-26 17:29:00-04:00,BAX,neutral
138643.0,"Greenlight Capital's Q2 Investor Letter: Brexit, Central Bank's 'Failing Policies,' Top Stock Picks And More",2016-07-26 14:20:00-04:00,BAX,negative
138644.0,"Greenlight's Q2 Investor Letter Shows Firm Bought: American Capital Agency, Baxter, Ingram Micro, Oil States, Covered Shorts in Intuitive Surgical, Under Armour, United Rentals Shares",2016-07-26 11:05:00-04:00,BAX,positive
138645.0,Baxter Raises FY16 EPS from Continuing Operations Before Special Items from $1.59-$1.67 to $1.69-$1.74 vs $1.64 Est.,2016-07-26 07:08:00-04:00,BAX,positive
138646.0,"Baxter Sees Q3 EPS from Continuing Operations Before Special Items $0.43-$0.45 vs $0.42 Est., Sales Growth on a Constant Currency Basis 3-4%",2016-07-26 07:07:00-04:00,BAX,positive
138647.0,"Baxter Reports Q2 Adj. EPS $0.46 vs $0.40 Est., Sales $2.6B vs $2.52B Est.",2016-07-26 07:06:00-04:00,BAX,neutral
138648.0,"Earnings Scheduled For July 26, 2016",2016-07-26 05:03:00-04:00,BAX,neutral
138649.0,Baxter Dividend Provides 1.1% Yield,2016-07-19 14:39:00-04:00,BAX,neutral
138650.0,Watch These 7 Huge Put Purchases In Monday Trade,2016-07-18 03:37:00-04:00,BAX,positive
138651.0,Option Alert: BAX 7/29 45.5 Puts (Wkly) Sweep: 1984 @  ASK  $0.47: 2000 traded vs 10 OI:  Earnings 7/26 Before Open  $46.81 Ref,2016-07-15 10:16:00-04:00,BAX,positive
138652.0,Spinoffs Are Outperforming Parent Companies,2016-07-07 13:47:00-04:00,BAX,neutral
138653.0,GE And Other Companies In Transition That Insiders Are Buying,2016-05-30 12:11:00-04:00,BAX,neutral
138654.0,Short Interest In Abbott Labs And Baxter International Doubles,2016-05-26 08:24:00-04:00,BAX,positive
138655.0,13F Season: David Einhorn's New Positions,2016-05-17 06:34:00-04:00,BAX,neutral
138656.0,"Dan Loeb's Q1 Moves: Allergan, Alphabet, Baxalta And More",2016-05-13 17:16:00-04:00,BAX,neutral
138657.0,13F Season: Some Early Trends For Q1 2016,2016-05-13 10:54:00-04:00,BAX,neutral
138658.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,BAX,neutral
138659.0,Short Interest In Baxter International And Celator Pharmaceuticals Doubles,2016-05-12 08:52:00-04:00,BAX,positive
138660.0,UPDATE: Baxter Sees FY18 Adj. EPS $2.10-$2.25; Sees FY20 Adj. EPS $2.75-$3,2016-05-09 16:10:00-04:00,BAX,neutral
138661.0,"Baxter Offers FY18, FY20 Outlook",2016-05-09 16:09:00-04:00,BAX,neutral
138662.0,Baxter Int'l Added To Goldman Sachs Conviction Buy List,2016-05-06 09:42:00-04:00,BAX,neutral
138663.0,Benzinga's Top Initiations,2016-05-04 09:47:00-04:00,BAX,positive
138664.0,The Market In 5 Minutes: May The Fourth,2016-05-04 09:24:00-04:00,BAX,neutral
138665.0,Evercore ISI Group Initiates Coverage on Baxter International at Buy,2016-05-04 06:56:00-04:00,BAX,neutral
138666.0,Baxter Increases Quarterly Dividend By 13%,2016-05-03 10:53:00-04:00,BAX,neutral
138667.0,Baxter Raises Qtr. Dividend From $0.115 To $0.13/Share,2016-05-03 08:34:00-04:00,BAX,neutral
138668.0,From Conf Call: Baxter Says Currency Weakness in Latin America Offers Acquisition Opportunities,2016-04-26 09:07:00-04:00,BAX,negative
138669.0,"Baxter Sees Q2 Adj. EPS $0.38-$0.40 vs $0.35 Est., Reported Sales Growth ~2%",2016-04-26 07:06:00-04:00,BAX,positive
138670.0,"UPDATE: Baxter Raises FY16 Adj. EPS Outlook from $1.46-$1.54 to $1.59-$1.67 vs $1.51 Est., Constant Currency Sales Growth ~3%, Sales Up ~1% on Reported Basis",2016-04-26 07:05:00-04:00,BAX,positive
138671.0,Baxter Raises FY16 Outlook,2016-04-26 07:04:00-04:00,BAX,neutral
138672.0,"Baxter Reports Q1 Adj. EPS $0.36 vs $0.29 Est., Sales $2.375B vs $2.35B Est.",2016-04-26 07:04:00-04:00,BAX,neutral
138673.0,"Earnings Scheduled For April 26, 2016",2016-04-26 04:26:00-04:00,BAX,neutral
138674.0,"Baxter Reports Received Marketing Authorization in UK, Denmark for NUMETA G13E Ready-to-Use IV Nutrition for Preterm Newborns",2016-04-20 08:01:00-04:00,BAX,neutral
138675.0,Baxter Reports US Launch of VANCOMYCIN Injection in Sodium Chloride,2016-04-19 08:17:00-04:00,BAX,neutral
138676.0,Baxter One Of Several Firms Said To Be Exploring An Acquisition Of India-Based Gland Pharma,2016-04-15 11:12:00-04:00,BAX,neutral
138677.0,"Piper: Baxter's Organic Cash Being Overlooked, Own Shares Heading Into May Analyst Day",2016-04-14 09:20:00-04:00,BAX,positive
138678.0,Benzinga's Top Upgrades,2016-04-14 09:15:00-04:00,BAX,positive
138679.0,"Piper Jaffray Upgrades Baxter International to Overweight, Raises PT to $58.00",2016-04-14 06:51:00-04:00,BAX,negative
138680.0,"Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",2016-04-12 09:25:00-04:00,BAX,neutral
138681.0,Baxter Reports Enrollment of First Patient in US Trial for VIVIA Investigational Home Hemodialysis System,2016-03-15 08:32:00-04:00,BAX,neutral
138682.0,Stocks To Watch During Cowen's 36th Annual Healthcare Conference,2016-03-01 13:21:00-05:00,BAX,neutral
138683.0,13F from Einhorn's Greenlight Shows New Stake in Baxter,2016-02-16 17:04:00-05:00,BAX,neutral
138684.0,13F from JANA Shows Reduced Stake in Baxter,2016-02-16 08:15:00-05:00,BAX,neutral
138685.0,13F from Starboard Shows Increased Stake in Baxter,2016-02-12 17:15:00-05:00,BAX,positive
138686.0,CORRECTION: Loeb's Third Point 13F Showed Maintained Stake in Baxter,2016-02-12 16:22:00-05:00,BAX,neutral
138687.0,Earnings Recap For February 2,2016-02-02 16:45:00-05:00,BAX,neutral
138688.0,"Baxter Sees FY16 Rev. up 2-3%, EPS $1.46-$1.54 vs. Est. $1.42",2016-02-02 07:01:00-05:00,BAX,neutral
138689.0,"Baxter Reports Q4 EPS $0.34 vs. Est. $0.32, Rev. $2.6B vs. Est. $2.55B",2016-02-02 07:00:00-05:00,BAX,neutral
138690.0,"Earnings Scheduled For February 2, 2016",2016-02-02 04:01:00-05:00,BAX,neutral
138691.0,This Firm Just Upgraded Shire On Attractive Valuation And Double-Digit EPS Growth,2016-01-12 08:17:00-05:00,BAX,positive
138692.0,Shire CEO Says Confident Deal Preserves Tax-Free Status of Baxalta's Spin-Out from Baxter,2016-01-11 08:16:00-05:00,BAX,positive
138693.0,"Benzinga's M&A Chatter for Wednesday January 6, 2016",2016-01-06 19:29:00-05:00,BAX,neutral
138694.0,Dividend Strategies To Consider In 2016,2016-01-06 09:45:00-05:00,BAX,neutral
138695.0,Baxalta Shares Higher Amid Report Of Shire Interest,2016-01-04 11:02:00-05:00,BAX,positive
138696.0,3 Year-End Golden Crosses To Watch,2015-12-24 11:34:00-05:00,BAX,neutral
138697.0,"Several Pharma/Biotech Names Spiking on AstraZeneca Rumor: Baxter, Shire, Baxalta",2015-12-11 12:41:00-05:00,BAX,neutral
138698.0,JANA Shows New ~12.6M Share Stake in Baxter,2015-11-16 15:35:00-05:00,BAX,positive
138699.0,"Piper Jaffray Assumes Baxter International at Overweight, Lowers $39.00 PT",2015-11-16 06:43:00-05:00,BAX,negative
138700.0,Loeb's Third Point Shows Increased Stake in Baxter by ~50M Shares,2015-11-13 16:58:00-05:00,BAX,positive
138701.0,"Dan Loeb Sees Yellen In 'Hotel California,' Is Short More Stocks Than He Is Long",2015-11-02 12:10:00-05:00,BAX,neutral
138702.0,"Baxter Names José Almeida Chairman, CEO",2015-10-28 16:46:00-04:00,BAX,neutral
138703.0,Baxter Close to Hiring Jose Almeida as CEO -DJ,2015-10-28 15:14:00-04:00,BAX,neutral
138704.0,Baxter International Spikes to High,2015-10-28 15:13:00-04:00,BAX,neutral
138705.0,"Baxter Sees 2H15 EPS $0.71-$0.73 vs. Previous $0.58-$0.62, Q4 EPS $0.30-$0.32",2015-10-27 07:20:00-04:00,BAX,neutral
138706.0,"Baxter International Q3 EPS $0.41 vs $0.29 est, Revenue $2.5B vs $2.46B est",2015-10-27 06:44:00-04:00,BAX,neutral
138707.0,"Earnings Scheduled For October 27, 2015",2015-10-27 04:14:00-04:00,BAX,neutral
138708.0,Baxter Reports FDA Clearance for AMIA Automated Peritoneal Dialysis System,2015-10-13 08:13:00-04:00,BAX,neutral
138709.0,14 Healthcare Stocks Fundstrat Is Buying,2015-10-05 11:39:00-04:00,BAX,neutral
138710.0,Major Hedge Funds Are Bullish On Baxter International And Layne Christensen,2015-09-30 16:17:00-04:00,BAX,neutral
138711.0,Baxter 13D Shows Dan Loeb's Third Point Holds 9.9% Stake As Of Sept 29,2015-09-30 09:20:00-04:00,BAX,neutral
138712.0,"Baxter Announces Deal with Third Point, Names Munib Islam to Board",2015-09-30 09:00:00-04:00,BAX,neutral
138713.0,Benzinga's Weekend M&A Chatter,2015-09-13 17:51:00-04:00,BAX,neutral
138714.0,Shire Looking for Way to Sweeten Offer for Baxalta by Launching Share Buyback and Getting Cash into Hands of Baxalta Shareholders Sooner -Wall Street Journal,2015-09-13 13:13:00-04:00,BAX,positive
138715.0,MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends,2015-09-08 07:59:00-04:00,BAX,negative
138716.0,Bloomberg TV:  Baxalta Ends Bid For Ariad,2015-09-02 09:32:00-04:00,BAX,neutral
138717.0,"Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff",2015-08-27 08:40:00-04:00,BAX,positive
138718.0,"Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical",2015-08-18 16:33:00-04:00,BAX,neutral
138719.0,13F from Loeb's Third Point Shows New Nearly 4M Share Stake in Baxter,2015-08-14 16:14:00-04:00,BAX,positive
138720.0,Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix,2015-08-14 09:00:00-04:00,BAX,positive
138721.0,"Hedge Fund Action: Dan Loeb Likes Baxter, Gabelli Prefers Global Sources",2015-08-05 17:23:00-04:00,BAX,positive
138722.0,"Baxter Press Release Confirms Earlier SEC Filing, PR Comments On Third Point 13D Filing",2015-08-05 15:18:00-04:00,BAX,neutral
138723.0,"Baxalta Baxter 13D Filing Shows 3rd Point Stake Of 7%, 3rd Point Seeking 2 Board Seats",2015-08-05 13:39:00-04:00,BAX,neutral
138724.0,UPDATE: Third Point Acquires 7% Stake in Baxter; Delivers Letter to Co,2015-08-05 13:35:00-04:00,BAX,neutral
138726.0,Mid-Day Market Update: Tuesday's Top 10 Volume Stocks,2015-08-04 14:35:00-04:00,BAX,positive
138727.0,"Mid-Day Market Update: Tuesday's Movers, China's New Short-Sell Rule, Greece's Stock Exchange",2015-08-04 13:00:00-04:00,BAX,neutral
138728.0,Hearing FDA Has Said Baxter Initiated a Nationwide Voluntary Recall of IV Solution,2015-07-31 12:41:00-04:00,BAX,positive
138729.0,Leerink Swann Downgrades Baxter International to Market Perform,2015-07-30 07:14:00-04:00,BAX,neutral
138730.0,"Baxter Reports Q2 Adj. EPS $1 vs $0.95 Est., Sales $3.9B vs $3.77B Est.; Sees Q3 EPS $0.29-$0.31 vs $0.27 Est.",2015-07-29 16:07:00-04:00,BAX,neutral
138731.0,"Earnings Scheduled For July 29, 2015",2015-07-29 04:38:00-04:00,BAX,neutral
138732.0,Baxter Investors Looking For Better Spot; BMO Downgrades Stock,2015-07-07 10:29:00-04:00,BAX,positive
138733.0,Benzinga's Top Downgrades,2015-07-07 09:29:00-04:00,BAX,positive
138734.0,Baxter International Announces Credit Agreements,2015-07-07 08:38:00-04:00,BAX,positive
138735.0,Unusual Call Activity In Baxter,2015-07-07 08:12:00-04:00,BAX,neutral
138736.0,BMO Capital Downgrades Baxter International to Market Perform,2015-07-07 06:57:00-04:00,BAX,neutral
138737.0,Benzinga's Top Downgrades,2015-07-02 09:32:00-04:00,BAX,positive
138738.0,Bank of America Downgrades Baxter International To Neutral,2015-07-02 09:07:00-04:00,BAX,neutral
138739.0,"BofA Upgrades Baxter International On 'Margin Story,' But Valuation Is Rich",2015-07-02 08:46:00-04:00,BAX,positive
138740.0,"Bank of America Downgrades Baxter International to Neutral, Lowers PT to $40.00",2015-07-02 07:46:00-04:00,BAX,negative
138741.0,Benzinga's Top Downgrades,2015-07-01 09:31:00-04:00,BAX,positive
138742.0,Credit Suisse Downgrades Baxter International to Neutral,2015-07-01 08:10:00-04:00,BAX,positive
138743.0,US Stock Futures Surge Ahead Of Jobless Claims,2015-06-25 08:10:00-04:00,BAX,neutral
138744.0,U.S. FDA Grants Priority Review for MM-398 New Drug Application,2015-06-25 07:05:00-04:00,BAX,positive
138745.0,Goldman Sachs Initiates Baxter International With Buy,2015-06-24 10:50:00-04:00,BAX,neutral
138746.0,Benzinga's Top Initiations,2015-06-24 09:59:00-04:00,BAX,positive
138747.0,"Baxalta Reports Continued Progress on Phase 1/2 Clinical Trial of BAX335, Investigational Gene Therapy Treatment for Hemophilia B",2015-06-24 09:01:00-04:00,BAX,positive
138748.0,"Goldman Sachs Initiates Coverage on Baxter International at Buy, Announces $45.00 PT",2015-06-24 07:02:00-04:00,BAX,neutral
138749.0,"Baxter, CTI Announces Pacritinib Phase 3 Study PERSIST-1 Study Shows Positive Results",2015-06-12 04:17:00-04:00,BAX,positive
138750.0,Baxter's Commitment to Innovative Programs and Advancing Its Sustainability Priorities Featured in Sixteenth Report,2015-06-10 09:00:00-04:00,BAX,positive
138752.0,Baxter Announces Effectiveness of Baxalta Form 10 Registration Statement,2015-06-09 17:04:00-04:00,BAX,neutral
138753.0,JMP Securities Boosts Halozyme Price Target On 'Long-Term Value',2015-06-04 10:17:00-04:00,BAX,positive
138754.0,"FDA Says Baxter Initiated Voluntary Recall Of Select Product Codes Of Peripheral Vascular Patch On June 1; Says Baxter Received Adverse Event Reports, Including Postoperative Thrombosis & Stroke",2015-06-03 12:55:00-04:00,BAX,negative
138755.0,"Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics",2015-06-01 09:03:00-04:00,BAX,neutral
138756.0,PharmaEngine Announces Filing NDA of MM-398 to Taiwan FDA as Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer,2015-06-01 04:24:00-04:00,BAX,negative
138758.0,Baxter BioScience Announces Filing of European Approval of Investigational 20% Subcutaneous Immune Globulin Treatment for Primary Immunodeficiency,2015-05-21 09:02:00-04:00,BAX,positive
138759.0,Baxter International Cites Novo Nordisk As Respondents In USITC Investigation For Violation Of Section 337 Of Certain Rcombinant Factor VIII Products,2015-05-18 15:47:00-04:00,BAX,negative
138760.0,"UPDATE: Baxter Looking for 'Double-Digit Adjusted Opearting Income Growth' Over '16-'20, Increase in Adj. EBITDA Margin from ~15% in 2H'15 to ~20% by '20",2015-05-18 08:50:00-04:00,BAX,positive
138761.0,"Baxter and Baxalta Holdings Outline Vision for Accelerated and Sustainable Growth, Showcase Innovation",2015-05-18 08:35:00-04:00,BAX,positive
138762.0,"Baxter Reports FDA Approval of 0.9% Sodium Chlordie Injection, USP from Sabinanigo, Spain Plant",2015-05-15 17:26:00-04:00,BAX,positive
138763.0,Baxter Intl's Baxter BioScience Announces Purchase of Oncaspar Product Portfolio from Sigma-Tau Finanziaria for $900M,2015-05-12 09:07:00-04:00,BAX,neutral
138764.0,"Baxter Bioscience, Merrimack Pharma Report Filing of European Approval for MM-398",2015-05-04 09:02:00-04:00,BAX,positive
138765.0,PharmaEngine Announces Merrimack Completed MM-398 NDA Submission to U.S. FDA,2015-04-27 21:10:00-04:00,BAX,neutral
138766.0,"Merrimack Pharma, Baxter BioScience Report Closing of NDA Submission to FDA for MM-398 for Treatment of Post-Gemcitabine Metastatic Pancreatic Cancer",2015-04-27 07:01:00-04:00,BAX,negative
138767.0,"Baxter Reports Q1 Adj. EPS $1 vs $0.88 Est., Sales $3.76B vs $3.7B Est.; Sees Q2 Adj. EPS $0.92-$0.96 vs $1.01 Est.",2015-04-23 07:04:00-04:00,BAX,neutral
138768.0,"Earnings Scheduled For April 23, 2015",2015-04-23 04:03:00-04:00,BAX,neutral
138769.0,CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO,2015-04-22 04:51:00-04:00,BAX,neutral
138770.0,Baxter Announces Submission of Application to Japan's MHLW for Approval of BAX 855,2015-04-16 09:00:00-04:00,BAX,positive
138771.0,"Baxter, Coherus Biosciences Report Amendment To Collaboration Agreement On Etanercept Biosimilar",2015-04-15 08:02:00-04:00,BAX,positive
138772.0,Baxter Announces Closing of CE Mark Approval for HOMECHOICE CLARIA,2015-04-01 08:02:00-04:00,BAX,positive
138773.0,Baxter's BioScience Unit Announces Positive Phase III Results for BAX 817,2015-03-13 09:00:00-04:00,BAX,positive
138774.0,CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis,2015-03-09 07:01:00-04:00,BAX,positive
138775.0,Baxter Announces BioScience Unit Has Purchase SuppreMol for $225M,2015-03-04 09:02:00-05:00,BAX,neutral
138776.0,"Baxter International Notified Momenta that it was Terminating in Part the Development, License and Option Agreement dated December 22, 2011 between Momenta and Baxter -8K",2015-02-17 08:44:00-05:00,BAX,positive
138777.0,Baxter Provides Progress Update on Gene Therapy Program,2015-02-12 16:30:00-05:00,BAX,positive
138778.0,Baxter Presents Additional Data from Pivotal Study of BAX 855,2015-02-11 09:03:00-05:00,BAX,neutral
138779.0,"Baxter Reports Q4 Adj. EPS from Cont. Ops $1.34 vs $1.31 Est., Sales $4.47B vs $4.34B Est.; Sees Q1 EPS $0.85-$0.90, Sales Growth 2-3%",2015-01-29 07:01:00-05:00,BAX,positive
138780.0,"Earnings Scheduled For January 29, 2015",2015-01-29 04:45:00-05:00,BAX,neutral
138781.0,Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy,2015-01-20 09:01:00-05:00,BAX,positive
138782.0,"Merrimack Pharma Offers Added Date Showing Support for MM-141, MM-151 for Pancreatic, Colorectal Cancer, Respectively",2015-01-20 08:07:00-05:00,BAX,negative
138783.0,What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts,2015-01-09 12:53:00-05:00,BAX,neutral
138784.0,What Investors Should Expect From Rockwell Medical's Next FDA Decision,2015-01-07 16:22:00-05:00,BAX,neutral
138785.0,"Pete Najarian's Picks For 2015: Citigroup, Foot Locker And More",2015-01-06 17:20:00-05:00,BAX,neutral
138786.0,What Investors Are Looking For After Seeing Unusual Options Activity In Halozyme,2015-01-06 12:15:00-05:00,BAX,neutral
138787.0,"Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease",2014-12-22 09:00:00-05:00,BAX,positive
138788.0,Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics,2014-12-15 09:01:00-05:00,BAX,neutral
138789.0,Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit,2014-12-10 17:16:00-05:00,BAX,neutral
138790.0,Baxter Reports Submission of Application for US FDA Approval of BAX 855,2014-12-01 09:00:00-05:00,BAX,positive
138791.0,Pfizer Reports Closing of Purchase of Baxter's Marked Vaccines Portfolio,2014-12-01 07:30:00-05:00,BAX,neutral
138792.0,Merrimack Pharma Reports FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer,2014-11-19 08:05:00-05:00,BAX,negative
138793.0,"Baxter Reports Investigational 20% Subcutaneous Immunoglobulin Treatment Has Met Efficacy, Tolerability Endpoints in Phase 2/3 Study",2014-10-30 09:01:00-04:00,BAX,neutral
138794.0,UPDATE: Baxter Announces FDA Approval of OBIZUR for Acquired Hemophilia A,2014-10-24 09:02:00-04:00,BAX,positive
138795.0,Baxter Announces FDA Approval of OBIZUR for Acquired Hemophilia A,2014-10-24 09:01:00-04:00,BAX,positive
138796.0,Baxter Reports Launch of HYQVIA in US for Adults with Primary Immunodeficiency,2014-10-20 09:03:00-04:00,BAX,neutral
138797.0,"Barclays Maintains Overweight on Baxter International Inc., Lowers PT to $83.00",2014-10-17 08:25:00-04:00,BAX,negative
138798.0,"UPDATE: Baxter Posts Upbeat Q3 Earnings, Issues Weak Earnings Forecast",2014-10-16 08:34:00-04:00,BAX,negative
138799.0,Baxter International Inc. Sees Q4 EPS $1.30-1.33 vs $1.41 Est,2014-10-16 07:11:00-04:00,BAX,neutral
138800.0,Baxter International Inc. Sees FY2014 EPS $4.86-4.89 Which May Not Compare $5.16 Est,2014-10-16 07:02:00-04:00,BAX,neutral
138801.0,Baxter International Inc. Reports Q3 EPS of $1.35 vs $1.31 Est; Revenue of $4.20B vs $4.21B Est,2014-10-16 07:01:00-04:00,BAX,neutral
138802.0,"Earnings Scheduled For October 16, 2014 ",2014-10-16 04:50:00-04:00,BAX,neutral
138803.0,UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin,2014-10-13 09:34:00-04:00,BAX,positive
138804.0,"Morgan Stanley Maintains Equal-weight on Baxter International Inc., Lowers PT to $75.00",2014-10-13 07:57:00-04:00,BAX,negative
138805.0,"Baxter Offers Details for Q3 Earnings Conference Call, Says Vaccines Franchise Will Be Reported as Discontinued Operation",2014-10-09 16:36:00-04:00,BAX,neutral
138806.0,UPDATE: Bank Of America Reiterates On Baxter International Inc. On Mixed Factors,2014-10-06 07:40:00-04:00,BAX,neutral
138807.0,Benzinga's Top #PreMarket Gainers,2014-10-03 08:44:00-04:00,BAX,positive
138808.0,"UPDATE: Rockwell Medical Will Receive $20M in Upfront Cash, $15M Investment Through Stock from Baxter",2014-10-03 07:16:00-04:00,BAX,neutral
138809.0,Rockwell Medical Reports Exclusive Long-Term Deal with Baxter for Commercialization of Hemodialysis Concentrates,2014-10-03 07:03:00-04:00,BAX,positive
138810.0,"PharmaEngine, Merrimack Amend MM-398 License Agreement ",2014-09-26 05:14:00-04:00,BAX,positive
138811.0,Stocks Gain While Dollar Reaches Highest Level Since 2010,2014-09-24 17:03:00-04:00,BAX,positive
138812.0,Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results,2014-09-24 15:54:00-04:00,BAX,positive
138813.0,U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast,2014-09-24 13:17:00-04:00,BAX,negative
138814.0,Markets Edge Lower; KB Home Posts Downbeat Results,2014-09-24 10:49:00-04:00,BAX,negative
138815.0,Morning Market Movers ,2014-09-24 09:40:00-04:00,BAX,neutral
138816.0,Benzinga's Top #PreMarket Gainers,2014-09-24 08:05:00-04:00,BAX,positive
138817.0,Merrimack Shares Rise 21% Premarket on Licensing Deal with Baxter,2014-09-24 07:29:00-04:00,BAX,positive
138818.0,Baxter And Merrimack Pharmaceuticals Enter Into Exclusive Ex-U.S. Licensing Agreement to Develop And Commercialize Novel Cancer Compound MM-398,2014-09-24 07:01:00-04:00,BAX,positive
138819.0,FDA Approves Baxter's RIXUBIS For Treatment Of Children With Hemophilia B,2014-09-15 09:01:00-04:00,BAX,positive
138820.0,Halozyme Shares Rise 9% Premarket Following FDA Approval of HYQVIA,2014-09-15 07:33:00-04:00,BAX,positive
138821.0,Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company ,2014-09-10 16:31:00-04:00,BAX,neutral
138822.0,Baxter to Begin Phase 3 Study of BAX 855,2014-08-21 15:36:00-04:00,BAX,neutral
138823.0,"Baxter Offers Positive Top-Line Results from Phase 3 Study of BAX 855, Regimen Results in 95% Reduction in Bleed Rate, Met Primary Endpoint",2014-08-21 09:01:00-04:00,BAX,positive
138824.0,Baxter To Invest $300M In Facility Opelika,2014-08-19 16:32:00-04:00,BAX,neutral
138825.0,Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives,2014-08-05 09:16:00-04:00,BAX,positive
138826.0,Baxter Reports FDA Okay for FLEXBUMIN 5% Solution,2014-08-04 09:00:00-04:00,BAX,positive
138827.0,Halozyme Therapeutics Receives Favorable FDA Decision,2014-07-31 14:45:00-04:00,BAX,positive
138828.0,PREVIEW: Halozyme Therapeutics to Resume Trading at 2:25 PM ET,2014-07-31 14:01:00-04:00,BAX,neutral
138829.0,FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's Hyqvia ror Primary Immunodeficiency;  Expects FDA Response In Q3,2014-07-31 13:56:00-04:00,BAX,positive
138830.0,Stocks Mixed Despite Better Than Expected GDP,2014-07-30 16:43:00-04:00,BAX,negative
138831.0,Pfizer Announces Acquisition of Baxter's Portfolio of Marketed Vaccines For $635M,2014-07-30 08:01:00-04:00,BAX,neutral
138832.0,FDA Reports Baxter Has Begun Recall of Four Lots of IV Solutions,2014-07-18 11:54:00-04:00,BAX,positive
138833.0,Baxter International Inc. Narrows FY2014 EPS Guidance from $5.05-5.25 to $5.10-5.20 vs $5.15 Est,2014-07-17 07:03:00-04:00,BAX,neutral
138834.0,Baxter International Inc. Sees Q3 EPS $1.28-1.32 vs $1.32 Est,2014-07-17 07:03:00-04:00,BAX,neutral
138835.0,Baxter International Inc. Reports Q2 EPS of $1.26 vs $1.22 Est; Revenue of $4.26B vs $4.12B Est,2014-07-17 07:00:00-04:00,BAX,neutral
138836.0,"Earnings Scheduled For July 17, 2014",2014-07-17 05:08:00-04:00,BAX,neutral
138837.0,"Baxter Appoints John Orloff, M.D., Vice President Of BioScience R&D",2014-07-10 09:01:00-04:00,BAX,neutral
138838.0,"Baxter Announces Purchase of AesRx, Terms Not Disclosed",2014-07-09 09:00:00-04:00,BAX,neutral
138839.0,"Baxter Names Robert Homach as CFO for Biopharma Spinoff, James Saccaro Named CFO",2014-07-07 09:03:00-04:00,BAX,neutral
138840.0,Baxter Says HyQvia Will Be Reviewed by FDA Advisory Panel on Jul. 31st,2014-06-25 09:20:00-04:00,BAX,neutral
138841.0,Baxter Presents Efficacy and Safety Data on VIVIA Haemodialysis System at ERA-EDTA Congress,2014-06-03 09:11:00-04:00,BAX,positive
138842.0,FDA Needs Additional Time to Review Baxter's HyQvia Supplementary Data,2014-05-21 09:03:00-04:00,BAX,neutral
138843.0,"Baxter Reports FDA Extension of PDUFA Date by Three Months, No Expecting BPAC Meeting on Jul. 31st",2014-05-21 09:02:00-04:00,BAX,negative
138844.0,Baxter Announces Receives 510(k) Clearance for NExt-Gen SIGMA Spectrum,2014-05-08 09:00:00-04:00,BAX,neutral
138845.0,Baxter International Raises Dividend 6%,2014-05-05 16:32:00-04:00,BAX,neutral
138846.0,Baxter Raises Qtr. Dividend from $0.49 to $0.52/Share,2014-05-05 16:31:00-04:00,BAX,neutral
138847.0,"FDA Announces Baxter Has Recalled Sigma Spectrum Infusion Pumps, Co. Has Reports of 9 Adverse Events in Malfunctions",2014-05-01 10:40:00-04:00,BAX,negative
138848.0,Baxter Announces FDA Approval of ADVATE,2014-04-23 09:00:00-04:00,BAX,positive
138849.0,Baxter International Inc. Sees fy EPS $4.67-4.87 vs $5.13 Est,2014-04-17 07:22:00-04:00,BAX,neutral
138850.0,Baxter International Inc. Sees Q2 EPS $1.18-1.22 vs $1.28 Est,2014-04-17 07:04:00-04:00,BAX,neutral
138851.0,Baxter International Inc. Reports Q1 EPS of $1.19 vs $1.09 Est; Revenue of $3.95B vs $3.88B Est,2014-04-17 07:03:00-04:00,BAX,neutral
138852.0,"Earnings Scheduled For April 17, 2014",2014-04-17 05:24:00-04:00,BAX,neutral
138853.0,"Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11 Was Met, Will File for Approval in US Before End of '14",2014-04-16 08:50:00-04:00,BAX,positive
138854.0,"Baxter Announces Purchase of Chatham Therapeutics, Will Make Initial Payment of $70M",2014-04-02 09:00:00-04:00,BAX,neutral
138855.0,FDA Says Fresenius Kabi USA Will Temporarily Distribute Normal Saline In US to Address Shortage,2014-03-28 14:55:00-04:00,BAX,negative
138856.0,Morgan Stanley Welcomes Shift in Sentiment on Baxter International,2014-03-28 09:40:00-04:00,BAX,positive
138857.0,"Not Too Late to Buy Baxter, Jim Cramer Says",2014-03-28 08:18:00-04:00,BAX,neutral
138858.0,Market Wrap For March 27: Markets Lower Following Mixed Economic Data,2014-03-27 17:39:00-04:00,BAX,negative
138859.0,Mid-Afternoon Market Update: Inovio Rallies on Vaccine Award; Citigroup Remains Down on Stress Test Results,2014-03-27 15:39:00-04:00,BAX,positive
138860.0,Mid-Day Market Update: US Stocks Fall; Citigroup Shares Slip After Failed Stress Test Results,2014-03-27 13:08:00-04:00,BAX,negative
138861.0,S&P Downgrades Baxter from A to A-; Outlook Negative,2014-03-27 11:33:00-04:00,BAX,negative
138862.0,Moody's Changes Baxter's Outlook to Negative on News of Bioscience Separation; Affirms A3 Ratings,2014-03-27 11:15:00-04:00,BAX,negative
138863.0,Benzinga's Volume Movers,2014-03-27 10:34:00-04:00,BAX,neutral
138864.0,Mid-Morning Market Update: Markets Mostly Flat; Lululemon Profit Beats Estimates,2014-03-27 10:31:00-04:00,BAX,positive
138865.0,Morgan Stanley Offers Quick Thoughts on Eloctate and Strategic Action Related to Baxter International,2014-03-27 10:20:00-04:00,BAX,neutral
138866.0,Morning Market Movers ,2014-03-27 09:41:00-04:00,BAX,neutral
138867.0,Benzinga's Top #PreMarket Gainers,2014-03-27 08:20:00-04:00,BAX,positive
138868.0,UPDATE: Baxter Shares Rise 8% Premarket Following Announcement of Split into Two Companies,2014-03-27 07:44:00-04:00,BAX,positive
138869.0,UPDATE: Baxter Details Plan to Create Two Separate Global Healthcare Cos.,2014-03-27 07:32:00-04:00,BAX,positive
138870.0,"UPDATE: Baxter Reports Biopharma Sales ~$6B Annually, Medical Product Sales ~$9B Annually",2014-03-27 07:32:00-04:00,BAX,neutral
138871.0,"Baxter Details Plan to Create Two Separate Global Healthcare Cos., Biopharma and Medical, Sees Charges",2014-03-27 07:30:00-04:00,BAX,neutral
138872.0,Form 8-K from Baxter Shows Co.'s Pres of Medical Products Robert Davis Resigned,2014-03-27 07:26:00-04:00,BAX,negative
138873.0,"Reuters Reports Baxter International Working With Goldman Sachsto Explore Vaccines Unit Sale, According to Sources ",2014-03-26 11:54:00-04:00,BAX,neutral
138874.0,Market Wrap For March 17: Investors Focused On Economic Data Instead Of Crimea Concerns,2014-03-17 16:45:00-04:00,BAX,positive
138875.0,UPDATE: Goldman Sachs Downgrades Baxter International as Increased Dependence on Pipeline Raises Risk,2014-03-17 10:04:00-04:00,BAX,neutral
138876.0,FDA Announces Baxter Has Initiated Voluntary Recall of One Lot of Peritoneal Dialysis Solution,2014-03-05 16:14:00-05:00,BAX,positive
138877.0,Morgan Stanley's View of Baxter International is Not Changed by Rigosertib's Phase III Failure,2014-02-20 07:49:00-05:00,BAX,negative
138878.0,FDA Sends Warning Letter to Baxter,2014-02-11 09:32:00-05:00,BAX,negative
138879.0,Baxter International Inc. Reports Q4 EPS of $1.26 vs $1.25 Est; Revenue of $4.37B vs $4.25B Est,2014-01-23 08:01:00-05:00,BAX,neutral
138880.0,Baxter International Inc. Sees Q1 EPS $1.06-1.09 vs $1.14 Est,2014-01-23 07:08:00-05:00,BAX,neutral
138881.0,Baxter International Inc. Sees FY2014 EPS $5.05-5.25 vs $5.01 Est,2014-01-23 07:07:00-05:00,BAX,neutral
138882.0,Baxter International Reports Q4 EPS of $1.26 vs $1.25 Est; Revenue of $4.37B vs $4.25B Est,2014-01-23 07:01:00-05:00,BAX,neutral
138883.0,"Earnings Scheduled For January 23, 2014",2014-01-23 04:49:00-05:00,BAX,neutral
138884.0,UPDATE: RBC Capital Markets Downgrades Baxter International ,2014-01-07 11:03:00-05:00,BAX,neutral
138885.0,"RBC Capital Downgrades Baxter International Inc. to Sector Perform, Maintains $73.00 PT",2014-01-07 08:24:00-05:00,BAX,neutral
138886.0,"RBC Capital Downgrades Baxter International Inc. to Sector Perform, Maintains $73.00 PT",2014-01-07 08:17:00-05:00,BAX,neutral
138887.0,"Baxter Initiates Voluntary Recall of Select Lots of 5% Dextrose Injection, USP, 09% Sodium Chloride Injection, USP IV Solutions",2013-12-23 16:32:00-05:00,BAX,positive
138888.0,Baxter Phase III Data Showed 72% Reduction In Median Annual Bleed Rate ,2013-12-19 09:07:00-05:00,BAX,neutral
138889.0,Baxter Receives FDA Approval of FEIBA,2013-12-19 09:01:00-05:00,BAX,positive
138890.0,Morgan Stanley Sees Factors That Could Spark Investor Interest in Baxter International,2013-12-16 10:18:00-05:00,BAX,positive
138891.0,"Baxter Issues Application for FDA Approval of OBI-1 for Patients with Acquired Hemophilia A, Granted Fast Track Designation",2013-12-10 09:04:00-05:00,BAX,positive
138892.0,"Baxter Submits Amended BLA to FDA for Hyqvia for Primary Immunodeficiency, Baxter, Halozyme Expecting Six-Month Review",2013-12-02 09:01:00-05:00,BAX,neutral
138893.0,Baxter Begins Voluntary Recall of One Lot of Nitroglycerin in 5% Dextrose,2013-11-27 09:01:00-05:00,BAX,neutral
138894.0,UPDATE: Credit Suisse Upgrades Baxter International Following Delay in U.S. Eloctate Approval,2013-11-18 10:30:00-05:00,BAX,positive
138895.0,Benzinga's Top Upgrades,2013-11-18 08:31:00-05:00,BAX,positive
138896.0,Credit Suisse Upgrades Baxter International Inc. to Outperform,2013-11-18 07:36:00-05:00,BAX,positive
138897.0,Cell Therapeutics Resumes Trade Up 36% on Deal with Baxter,2013-11-15 08:03:00-05:00,BAX,neutral
138898.0,"Baxter, Cell Therapeutics Report Worldwide Strategic Pact to Develop Pacritinib, Baxter Will Make an Upfront Payment of $60M",2013-11-15 07:30:00-05:00,BAX,neutral
138899.0,Baxter Closes Enrollment in Phase 3 Trial of BAX 855,2013-11-13 09:00:00-05:00,BAX,neutral
138900.0,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,2013-11-12 16:41:00-05:00,BAX,positive
138901.0,Baxter Issues Application for European Approval of RIXUBIS,2013-10-31 09:00:00-04:00,BAX,positive
138902.0,Cowen & Company Downgrades Baxter International Inc. to Market Perform,2013-10-23 09:25:00-04:00,BAX,neutral
138903.0,Morgan Stanley Downgrades Baxter International Inc. to Equalweight,2013-10-18 07:36:00-04:00,BAX,neutral
138904.0,"Raymond James Downgrades Baxter International Inc. to Market Perform, Removes $80.00 PT",2013-10-18 07:20:00-04:00,BAX,neutral
138905.0,Baxter International Inc. Narrows FY2013 EPS Guidance from $4.62-4.70 to $4.65-4.67 vs $4.67 Est,2013-10-17 07:03:00-04:00,BAX,neutral
138906.0,Baxter International Inc. Sees Q4 EPS $1.24-1.26 vs $1.26 Est,2013-10-17 07:02:00-04:00,BAX,neutral
138907.0,"Baxter International Inc. Reports Q3 EPS of $1.19, Inline; Revenue of $3.77B vs $3.82B Est",2013-10-17 07:02:00-04:00,BAX,neutral
138908.0,"Earnings Scheduled For October 17, 2013",2013-10-17 04:43:00-04:00,BAX,neutral
138909.0,UPDATE: Citigroup Lowers PT on Baxter International on Lowered Estimates,2013-10-14 11:44:00-04:00,BAX,negative
138910.0,Credit Suisse Downgrades Baxter International Inc. to Neutral,2013-10-02 07:47:00-04:00,BAX,positive
138911.0,"JP Morgan Upgrades Baxter International Inc. to Neutral, Announces $76.00 PT",2013-09-25 07:43:00-04:00,BAX,positive
138912.0,Baxter Reports Voluntary Recall of Two Lots of Dual Luer Lock Caps ,2013-09-19 16:47:00-04:00,BAX,neutral
138913.0,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",2013-09-14 11:47:00-04:00,BAX,positive
138914.0,"ICU Medical Spikes Higher, May be Attributed to Deal Reporter Story on Possible Sale",2013-09-12 14:00:00-04:00,BAX,neutral
138915.0,"Baxter Names Todd Young Treasruer, Corporate Officer, Succeeding Saccaro",2013-09-09 09:03:00-04:00,BAX,positive
138916.0,US Stock Futures Mixed; Jobs Report In Focus,2013-09-06 07:17:00-04:00,BAX,neutral
138917.0,Baxter Completes Acquisition of Gambro AB ,2013-09-06 07:02:00-04:00,BAX,neutral
138918.0,CL King Upgrades Baxter International Inc. to Buy,2013-09-04 09:33:00-04:00,BAX,neutral
138919.0,"Baxter, Coherus Biosciences Report Collaboration to Develop, Commercialize Biosimilars",2013-09-03 09:03:00-04:00,BAX,neutral
138920.0,"Form 8-K from Baxter Shows Co. Indap Have Amended Share Purchase Plan, Long-Stop Date Extended to Sept. 30th",2013-08-28 16:26:00-04:00,BAX,positive
138921.0,"Baxter, JW Holdings Announce Exclusive Distribution and License  Agreement for Omega 3 Parenteral Nutrition Products ",2013-07-31 05:57:00-04:00,BAX,positive
138922.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Profit Margin,2013-07-26 04:18:00-04:00,BAX,positive
138923.0,European Medicines Agency Approves SmPC Change to Baxter's ADVATE ,2013-07-23 05:52:00-04:00,BAX,positive
138924.0,"Baxter Says EMA Authorized SmPC Change to ADVATE, Will Include Info on PK-Guided Dosing Study",2013-07-22 09:02:00-04:00,BAX,neutral
138925.0,Baxter International Earnings Mixed (BAX),2013-07-18 10:46:00-04:00,BAX,neutral
138926.0,Baxter International Inc. Raises FY2013 EPS Guidance from $4.60-4.70 to $4.62-4.70 vs $4.66 Est,2013-07-18 07:22:00-04:00,BAX,neutral
138927.0,UPDATE: Baxter Sees Full Year Sales Growth Including Gambro 8-9% Excluding Forex vs. 10% Previous,2013-07-18 07:07:00-04:00,BAX,positive
138928.0,Baxter International Inc. Sees Q3 EPS $1.18-1.21 vs $1.18 Est,2013-07-18 07:06:00-04:00,BAX,neutral
138929.0,Baxter International Inc. Reports Q2 EPS of $1.16 vs $1.13 Est; Revenue of $3.67B vs $3.70B Est,2013-07-18 07:06:00-04:00,BAX,neutral
138930.0,US Stock Futures Flat Ahead Of Jobless Claims,2013-07-18 06:07:00-04:00,BAX,neutral
138931.0,"Earnings Scheduled For July 18, 2013",2013-07-18 04:27:00-04:00,BAX,neutral
138932.0,Baxter Presents Additional Data from Phase III Study of Immunoglobulin for Alzheimer's Disease at AAIC,2013-07-16 08:31:00-04:00,BAX,neutral
138933.0,UPDATE: Credit Suisse Initiates Baxter International at Outperform on Solid Top-Line Growth,2013-07-10 09:36:00-04:00,BAX,positive
138934.0,"Credit Suisse Initiates Coverage on Baxter International Inc. at Outperform, Announces $81.00 PT",2013-07-10 07:30:00-04:00,BAX,positive
138935.0,Financial Times Reporting That China Is Investigating 33 Foreign Pharmaceutical Companies For Pricing Irregularities,2013-07-04 07:27:00-04:00,BAX,neutral
138936.0,FROM EARLIER: FDA Approves First Recombinant Coagulation Factor IX,2013-06-27 13:40:00-04:00,BAX,positive
138937.0,FDA Approves Baxter's RIXUBIS as First Recombinant Factor IX Treatment for Routine Prophylaxis of Hemophilia B ,2013-06-27 09:03:00-04:00,BAX,positive
138938.0,Baxter Approval to Treat Routine Prophylaxis of Hemophilia B,2013-06-27 09:03:00-04:00,BAX,positive
138939.0,"Baxter Healthcare Announces FDA Warning Letter Dated May 31st, FDA Says Baxter's Response Lacks Sufficient Corrective Actions",2013-06-11 09:25:00-04:00,BAX,negative
138940.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest ROE,2013-06-07 06:47:00-04:00,BAX,positive
138941.0,"Bank of America Maintains Buy on Baxter International Inc., Raises PO to $80.00",2013-05-16 12:00:00-04:00,BAX,negative
138942.0,"Morgan Stanley Maintains Overweight on Baxter International Inc., Lowers PT to $81.00",2013-05-14 10:09:00-04:00,BAX,negative
138943.0,Barclays Upgrades Baxter International Inc. to Overweight,2013-05-07 13:39:00-04:00,BAX,negative
138944.0,Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease ,2013-05-07 07:15:00-04:00,BAX,neutral
138945.0,Baxter Raises Dividend 9% to $0.49 per Share,2013-05-06 17:01:00-04:00,BAX,positive
138946.0,Baxter Raises Qtr. Dividend from $0.45 to $0.49/Share,2013-05-06 17:00:00-04:00,BAX,neutral
138947.0,A Peek Into The Market Before The Trading Starts,2013-05-06 07:23:00-04:00,BAX,neutral
138948.0,Vical's Vaxfectin Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines ,2013-05-06 06:47:00-04:00,BAX,positive
138949.0,Illumina and Other Bargain Biotech Stocks Worth a Look Now,2013-05-01 12:57:00-04:00,BAX,positive
138950.0,Baxter to Issue Phase I/II Data on Lyme Disease Vaccine at NFID Annual Conferenc,2013-04-24 09:02:00-04:00,BAX,neutral
138951.0,"Baxter Sees FY Gross Margin 50.5%, CapEx $1.7B, Cash Flow from Ops. $3.3B",2013-04-18 08:50:00-04:00,BAX,negative
138952.0,"Baxter International Inc. Sees Q2 EPS $1.12-1.14 vs $1.14 Est, Sees Sales Growth Ex ForEx 4%",2013-04-18 07:10:00-04:00,BAX,positive
138953.0,US Stock Futures Up Ahead Of Weekly Jobless Claims Data,2013-04-18 06:20:00-04:00,BAX,neutral
138954.0,"Earnings Scheduled For April 18, 2013",2013-04-18 05:36:00-04:00,BAX,neutral
138955.0,"Baxter Shares Unaffected as Traders Digesting News of Orphan Status for Feiba, FDA Warning Letter Related to SIGMA Spectrum Infusion Pump with Master Drug Library",2013-04-16 13:36:00-04:00,BAX,negative
138956.0,"Piper Jaffray Maintains Overweight on Baxter International Inc., Raises PT to $81.00",2013-04-15 10:50:00-04:00,BAX,negative
138957.0,"Deutsche Bank Maintains Hold on Baxter International Inc., Raises PT to $75.00",2013-04-12 07:32:00-04:00,BAX,neutral
138958.0,These Are the 100 Highest-Paid CEOs in Business Today,2013-04-08 16:30:00-04:00,BAX,neutral
138959.0,UPDATE: Morgan Stanley Raises PT on Baxter International on Neutral Risk-Reward,2013-03-25 13:17:00-04:00,BAX,neutral
138960.0,"Morgan Stanley Maintains Overweight on Baxter International Inc., Raises PT to $84.00",2013-03-25 07:41:00-04:00,BAX,negative
138961.0,"Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)",2013-03-23 11:33:00-04:00,BAX,positive
138962.0,"Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus",2013-03-22 16:17:00-04:00,BAX,positive
138963.0,"Mid-Day Market Update: Micron Surges On Upbeat Revenue, Informatica Declines",2013-03-22 13:23:00-04:00,BAX,neutral
138964.0,Baxter and Halozyme Announce Positive Opinion for HyQvia for Treatment of Primary and Secondary Immunodeficiencies in the European Union ,2013-03-22 08:31:00-04:00,BAX,positive
138965.0,"EMA Gives Positive Opinion's on Baxter's Hyqvia, ARIAD Pharma's Iclusig, Gilead's Stribild",2013-03-22 08:28:00-04:00,BAX,positive
138966.0,Are Scientists Edging Closer to a Cure for Alzheimer's?,2013-03-11 08:58:00-04:00,BAX,neutral
138967.0,"Sky News Reporting Baxter, Investors Seen Bidding for Plasma Resources",2013-03-05 08:52:00-05:00,BAX,neutral
138968.0,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",2013-02-28 15:13:00-05:00,BAX,positive
138969.0,Top 4 NYSE Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue Estimates,2013-02-27 05:44:00-05:00,BAX,positive
138970.0,Baxter to Buy OBI-1 from Inspiration BioPharma for Upfront Payment of $50M,2013-01-24 07:12:00-05:00,BAX,positive
138971.0,Baxter International Inc. Sees FY2013 EPS $4.60-4.70 vs $4.81 Est,2013-01-24 07:02:00-05:00,BAX,neutral
138972.0,Baxter International Inc. Sees Q1 EPS $1.03-1.05 vs $1.09 Est,2013-01-24 07:02:00-05:00,BAX,neutral
138973.0,"Baxter International Inc. Reports Q4 EPS of $1.26, Inline; Revenue of $3.75B vs $3.72B Est",2013-01-24 07:02:00-05:00,BAX,neutral
138974.0,US Stock Futures Mixed After Disappointing Apple Results,2013-01-24 05:38:00-05:00,BAX,negative
138975.0,"Earnings Scheduled For January 24, 2013",2013-01-24 02:45:00-05:00,BAX,neutral
138976.0,One Biotech Stock Investors are Unfairly Ignoring,2013-01-15 09:00:00-05:00,BAX,negative
138977.0,Baxter Offers Phase III Data on Prophylaxis Treatment of FEIBA NF,2013-01-08 09:01:00-05:00,BAX,neutral
138978.0,"Baxter to Initiate Late-Stage Trial of BAX855, Sees Phase Study in Q1",2013-01-07 09:03:00-05:00,BAX,neutral
138979.0,"Deutsche Bank Maintains Hold on Baxter International Inc., Raises PT to $71.00",2013-01-04 09:19:00-05:00,BAX,neutral
138980.0,"Morgan Stanley Maintains Overweight on Baxter International Inc., Raises PT to $71.00",2012-12-20 10:40:00-05:00,BAX,negative
138981.0,"Baxter Presents Phase I/III Data Evaluating Safety, Efficacy of BAX 326",2012-12-10 09:01:00-05:00,BAX,positive
138982.0,"A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)",2012-12-08 23:17:00-05:00,BAX,positive
138983.0,S&P Downgrades Baxter from A+ to A,2012-12-06 11:16:00-05:00,BAX,neutral
138984.0,"Bank of America Merrill Lynch Reiterates Buy Rating, $70 PO on Baxter International",2012-12-05 08:10:00-05:00,BAX,negative
138985.0,"Benzinga's M&A Chatter for Tuesday December 4, 2012",2012-12-04 17:24:00-05:00,BAX,neutral
138986.0,Goldman Sachs Moves to Not Rated on Baxter International,2012-12-04 10:55:00-05:00,BAX,neutral
138987.0,"JP Morgan Suspends Coverage on Baxter International, Removes PT",2012-12-04 10:49:00-05:00,BAX,positive
138988.0,Baxter Acquires Dialysis Product Company Gambro ,2012-12-04 07:12:00-05:00,BAX,neutral
138989.0,Baxter Exec at Piper Jaffray Healthcare Conference Won't Comment on Gambro Rumor,2012-11-27 13:05:00-05:00,BAX,neutral
138990.0,Benzinga's Top Downgrades,2012-11-27 09:02:00-05:00,BAX,positive
138991.0,UPDATE: JP Morgan Reiterates Baxter International at Overweight; Gambro Expensive but Worth It  ,2012-11-26 14:23:00-05:00,BAX,positive
138992.0,Some Setups to Watch in the Week Ahead,2012-11-26 14:08:00-05:00,BAX,neutral
138993.0,UPDATE: Morgan Stanley Reiterates Baxter International at Overweight Despite Deal Concerns ,2012-11-26 13:40:00-05:00,BAX,negative
138994.0,UPDATE: Bank of America Raises PT to $70 on Baxter International; Gambro Strategic Fit at Steep Price  ,2012-11-26 13:39:00-05:00,BAX,positive
138995.0,"CORRECTION: Bank of America Maintains Baxter International at Buy, Raises PO to $70",2012-11-26 13:26:00-05:00,BAX,negative
138996.0,"J.P.Morgan Reiterates Baxter International at Overweight , Maintains PT at $68.00",2012-11-26 13:21:00-05:00,BAX,negative
138997.0,"Bank of America Maintains Baxter International at Buy, Raises PO to $17",2012-11-26 13:12:00-05:00,BAX,negative
138998.0,Baxter International in Talks to Buy Sweden's Gambro -WSJ,2012-11-23 10:30:00-05:00,BAX,neutral
138999.0,"UPDATE: Baxter Talking with Swiss MedTech Co. Gambro, Deal Could Be Worth $4B - WSJ",2012-11-23 10:27:00-05:00,BAX,positive
139000.0,Baxter Talking with Swiss MedTech Co. Gambro - WSJ,2012-11-23 10:20:00-05:00,BAX,neutral
139001.0,UPDATE: Stifel Nicolaus Initiates Baxter International at Hold; Looking for Better Entry  ,2012-11-20 12:22:00-05:00,BAX,positive
139002.0,Stifel Nicolaus Initiates Coverage on Baxter International at Hold,2012-11-20 08:20:00-05:00,BAX,neutral
139003.0,"Barclays Maintains Baxter International at Equal-weight, Raises PT from $63 to $68",2012-11-15 13:09:00-05:00,BAX,neutral
139004.0,Benzinga's Top Initiations,2012-11-14 07:41:00-05:00,BAX,positive
139005.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest ROA,2012-11-14 02:30:00-05:00,BAX,positive
139006.0,Best & Worst ETFs and Mutual Funds: Large Cap Value Style,2012-11-07 17:20:00-05:00,BAX,positive
139007.0,NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors ,2012-10-23 17:00:00-04:00,BAX,neutral
139008.0,UPDATE: Baxter Guides FY13 Growth at Low End of 7-9% Range,2012-10-18 08:55:00-04:00,BAX,positive
139009.0,Baxter Says Sees Year R+D Growth in Single Digits; 2013 Environment Will Remain Challenging; Underlying Business Drivers Solid,2012-10-18 08:52:00-04:00,BAX,positive
139010.0,Baxter International Reports Q3 EPS $1.14 vs $1.14 Est; Revenues $3.48B vs $3.52B Est,2012-10-18 07:02:00-04:00,BAX,neutral
139011.0,"US Stock Futures Flat; Morgan Stanley Earnings, Jobless Claims Data In Focus",2012-10-18 06:03:00-04:00,BAX,neutral
139012.0,"Earnings Scheduled For October 18, 2012",2012-10-18 03:22:00-04:00,BAX,neutral
139013.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Operating Margin,2012-10-18 03:08:00-04:00,BAX,positive
139014.0,"Piper Jaffray Maintains Baxter International at Overweight, Raises PT from $65 to $73",2012-10-11 06:33:00-04:00,BAX,negative
139015.0,"Citigroup Maintains Baxter International at Neutral, Raises PT from $57 to $60",2012-10-10 08:46:00-04:00,BAX,neutral
139016.0,Baxter Announces That it Plans to Offer $750M in Buybacks -Bloomberg,2012-10-09 12:16:00-04:00,BAX,neutral
139017.0,UPDATE: Baxter Guides FY12 Free Cash Flow About $2B; FY12 Capex $1B or More; FY17 Capex About $1.5B,2012-10-09 10:49:00-04:00,BAX,positive
139018.0,Baxter Reaffirms FY12 EPS $4.50-4.56 vs $4.53 Est,2012-10-09 10:47:00-04:00,BAX,neutral
139019.0,UPDATE: Baxter Sees Driving Growth Through Acquisitions; Sees FY12 R+D Costs About 7% of Sales; FY17 Operating Margin 24-25%,2012-10-09 10:45:00-04:00,BAX,positive
139020.0,"UPDATE: Baxter Says Emerging Markets Will be 30% of Sales by 2017, Gross Margin Will be 52-53%",2012-10-09 10:42:00-04:00,BAX,negative
139021.0,UPDATE: Baxter Says Implementing New Reporting Structure; Will Provide Restated Results for Past 3 Years,2012-10-09 10:37:00-04:00,BAX,neutral
139022.0,Baxter Guides FY12 EPS $4.50-4.56 vs $4.53 Est; Guides FY12 Sales Growth 4-5%,2012-10-09 10:34:00-04:00,BAX,positive
139023.0,UPDATE: Baxter Says Plans Bolt-On Acquisitions,2012-10-09 10:31:00-04:00,BAX,neutral
139024.0,Baxter Guides Boosting EPS 7-9% on CAGR Over 5-Year Plan,2012-10-09 08:35:00-04:00,BAX,positive
139025.0,"UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Baxter International",2012-10-01 10:52:00-04:00,BAX,negative
139026.0,"JP Morgan Maintains Baxter International at Overweight, Raises PT from $63 to $65",2012-10-01 07:21:00-04:00,BAX,neutral
139027.0,Baxter Appoints Two New Directors to Its Board  ,2012-09-27 16:15:00-04:00,BAX,neutral
139028.0,"UPDATE: Deutsche Bank Downgrades Baxter International to Hold, Reiterates $63 PT",2012-09-24 10:28:00-04:00,BAX,neutral
139029.0,"Deutsche Bank Downgrades Baxter International from Buy to Hold, Maintains PT at $63",2012-09-24 06:12:00-04:00,BAX,neutral
139030.0,"UPDATE: BMO Capital Markets Initiates Coverage on Baxter International with Outperform Rating, $70 PT",2012-09-19 12:24:00-04:00,BAX,neutral
139031.0,Onconova May Receive up to $515M in Milestones,2012-09-19 08:32:00-04:00,BAX,neutral
139032.0,"BMO Capital Markets Initiates Coverage on Baxter International at Outperform, Announces PT of $70",2012-09-19 07:33:00-04:00,BAX,neutral
139033.0,Benzinga's Top Initiations,2012-09-19 07:33:00-04:00,BAX,positive
139034.0,Baxter International Spikes to 52-Week High on Heavy Volume,2012-09-13 09:46:00-04:00,BAX,neutral
139035.0,Baxter Initiates Phase I Clinical Trial With Anti-MIF Antibody in Patients with Solid Tumors  ,2012-09-05 09:02:00-04:00,BAX,positive
139036.0,Baxter Submits Application for FDA Approval of Recombinant Factor IX,2012-09-04 09:01:00-04:00,BAX,positive
139037.0,Baxter Files Automatic Debt Securities Shelf,2012-08-06 17:24:00-04:00,BAX,negative
139038.0,"Goldman Sachs Maintains Baxter International at Buy, Raises PT from $64 to $67",2012-07-25 14:01:00-04:00,BAX,neutral
139039.0,Baxter Raises Dividend 34% and Announces New $2B Share Repurchase Program,2012-07-25 08:16:00-04:00,BAX,positive
139040.0,"UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on Baxter International",2012-07-20 12:12:00-04:00,BAX,neutral
139041.0,"Deutsche Bank Maintains Baxter International at Buy, Raises PT from $62 to $63",2012-07-20 06:10:00-04:00,BAX,neutral
139042.0,"Financial Breakfast: Morning News Summary for July 19, 2012",2012-07-19 07:38:00-04:00,BAX,neutral
139043.0,Baxter Reports Q2 EPS $1.12 vs $1.11 Est; Revs $3.57B vs $3.53B Est,2012-07-19 07:05:00-04:00,BAX,neutral
139044.0,Baxter Announces Collaboration with Sanquin to Expand Capacity for Plasma Therapies   ,2012-07-19 06:48:00-04:00,BAX,positive
139045.0,Earnings Scheduled For July 19,2012-07-19 02:56:00-04:00,BAX,neutral
139046.0,Baxter's Gammagard 'Tantalizing' for Alzheimer's in Small Study -Bloomberg,2012-07-17 11:33:00-04:00,BAX,neutral
139047.0,Baxter International Spiking Higher,2012-07-17 11:31:00-04:00,BAX,neutral
139048.0,Baxter Announces FDA Approval of ADVATE 4000 IU Dosage Strength,2012-07-16 09:01:00-04:00,BAX,positive
139049.0,"Citigroup Maintains Baxter International at Neutral, Raises PT from $56 to $57",2012-07-09 08:45:00-04:00,BAX,neutral
139050.0,Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy,2012-06-25 09:01:00-04:00,BAX,positive
139051.0,UPDATE: Goldman Sachs Raises PT on Baxter International to $64,2012-06-19 09:02:00-04:00,BAX,neutral
139052.0,Goldman Sachs Adds Baxter International to CL-Buy List,2012-06-19 06:53:00-04:00,BAX,neutral
139053.0,Baxter Announces Collaboration with Chatham Therapeutics for Factor IX,2012-06-04 09:01:00-04:00,BAX,neutral
139054.0,Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A   ,2012-05-16 09:02:00-04:00,BAX,positive
139055.0,"Paulson Increased Stakes in Hartford, Baxter, El Paso, MGM, Mylan",2012-05-15 17:25:00-04:00,BAX,positive
139056.0,Stem Cell Biotechs:  A Frontrunner Emerges?,2012-04-21 00:33:00-04:00,BAX,neutral
139057.0,"UBS Maintains Baxter International at Buy, Lowers PT from $66 to $64",2012-04-20 11:49:00-04:00,BAX,negative
139058.0,UPDATE: Deutsche Bank Cuts PT to $64 on Baxter International  ,2012-04-20 10:48:00-04:00,BAX,negative
139059.0,UPDATE: Citi Lowers Baxter's PT,2012-04-20 09:42:00-04:00,BAX,negative
139060.0,"Citigroup Maintains Baxter International at Neutral, Lowers PT from $57 to $56",2012-04-20 07:47:00-04:00,BAX,negative
139061.0,"Deutsche Bank Maintains Baxter International at Buy, Lowers PT from $64 to $62",2012-04-20 06:15:00-04:00,BAX,negative
139062.0,Earnings Roundup,2012-04-19 08:32:00-04:00,BAX,neutral
139063.0,Baxter International Reports Q1 EPS $1.01 vs $1 Est; Revenues $3.4B vs $3.30B Est,2012-04-19 07:06:00-04:00,BAX,neutral
139064.0,Baxter Announces Biologics Capacity Expansion to Support Global Growth in Plasma-Derived Therapies   ,2012-04-19 06:53:00-04:00,BAX,positive
139065.0,Earnings Scheduled For April 19,2012-04-19 04:43:00-04:00,BAX,neutral
139066.0,"Morning Social Media Outlook for Friday April 17 (DTSI, USB, GCI, BAX)",2012-04-17 10:11:00-04:00,BAX,neutral
139067.0,Notable Options Activity in BAX,2012-04-16 13:22:00-04:00,BAX,neutral
139068.0,Baxter and Halozyme Provide Update on HyQ Biologics License Application ,2012-04-16 08:01:00-04:00,BAX,neutral
139069.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,BAX,positive
139070.0,"Caterpillar, Discover Financial and Other Illinois Primary Stock Picks",2012-03-20 06:42:00-04:00,BAX,neutral
139071.0,"Morgan Stanley Maintains Baxter International at Overweight, Raises PT from $58 to $68",2012-03-20 06:17:00-04:00,BAX,negative
139072.0,UPDATE: Dougherty & Company Raises PT on Baxter International to $56,2012-03-05 14:55:00-05:00,BAX,neutral
139073.0,"Dougherty & Company Maintains Baxter International at Neutral, Raises PT from $53 to $56",2012-03-05 12:54:00-05:00,BAX,neutral
139074.0,Baxter Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine,2012-03-02 09:00:00-05:00,BAX,neutral
139075.0,"UBS Maintains Baxter International at Buy, Raises PT from $63 to $66",2012-02-28 12:35:00-05:00,BAX,neutral
139076.0,Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition   ,2012-02-28 09:02:00-05:00,BAX,neutral
139077.0,"Financial Breakfast: Morning News Summary for February 24, 2012",2012-02-24 07:23:00-05:00,BAX,neutral
139078.0,"Citigroup Upgrades Baxter International from Sell to Neutral, Raises PT from $53 to $57",2012-02-24 06:24:00-05:00,BAX,neutral
139079.0,Standpoint Research Downgrades Baxter International from Buy to Hold,2012-02-16 13:17:00-05:00,BAX,neutral
139080.0,Seven Hot Chinese Stocks,2012-02-14 06:37:00-05:00,BAX,neutral
139081.0,Top Performing Health Care Stocks in January,2012-02-01 06:32:00-05:00,BAX,positive
139082.0,Baxter Announces FDA Approval of Expanded Indication for TISSEEL for General Hemostasis in Surgery  ,2012-01-30 09:00:00-05:00,BAX,positive
139083.0,Piper Jaffray Lowers PT on Baxter International to $65,2012-01-27 10:26:00-05:00,BAX,negative
139084.0,Baxter International Reports Q4 EPS $1.17 vs $1.17 Est; Revenues $3.59B vs $3.58B Est			 ,2012-01-26 07:23:00-05:00,BAX,neutral
139085.0,Morgan Keegan Reports Baxter to Initiate Second PIII Alzheimer's Disease Trial,2012-01-24 09:52:00-05:00,BAX,neutral
139086.0,Morgan Stanley Maintains Overweight Rating on Baxter International,2012-01-24 07:05:00-05:00,BAX,negative
139087.0,From Earlier: Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID for the Treatment of Alzheimer's Disease  ,2012-01-24 06:43:00-05:00,BAX,neutral
139088.0,J.P. Morgan Maintains Overweight Rating on Baxter Intl,2012-01-17 07:02:00-05:00,BAX,negative
139089.0,Feltl and Company Downgrades Synovis Life Technologies to Sell,2012-01-11 12:24:00-05:00,BAX,neutral
139090.0,"JP Morgan Reiterates Overweight, $60 Target on Baxter International ",2012-01-11 08:42:00-05:00,BAX,neutral
139091.0,Baxter Submits Application for FDA Approval of GAMMAGARD LIQUID to Treat Multifocal Motor Neuropathy,2012-01-09 09:00:00-05:00,BAX,positive
139092.0,Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A  ,2012-01-05 08:35:00-05:00,BAX,neutral
139093.0,"Baxter Recommends Shareholders Reject ""Mini-Tender"" Offer by TRC Capital   ",2012-01-04 17:12:00-05:00,BAX,negative
139094.0,Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-On Biologics; Baxter to Make Upfront Cash Payment of $33M    ,2011-12-22 16:15:00-05:00,BAX,neutral
139095.0,RBC Capital Downgrades Baxter International to Outperform,2011-12-20 09:59:00-05:00,BAX,neutral
139096.0,Baxter International Hits 52-Week Low of $47.68,2011-12-19 15:29:00-05:00,BAX,negative
139097.0,FDA Approves Baxter's ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A   ,2011-12-16 09:15:00-05:00,BAX,positive
139098.0,Piper Jaffray Lowers PT on Baxter International to $66,2011-12-16 06:30:00-05:00,BAX,negative
139099.0,"Benzinga's M&A Chatter for Tuesday December 13, 2011",2011-12-13 17:33:00-05:00,BAX,neutral
139100.0,Top Narrow Based Indexes For December 13,2011-12-13 10:00:00-05:00,BAX,positive
139101.0,Morning Market Movers,2011-12-13 09:45:00-05:00,BAX,neutral
139102.0,UPDATE: J.P. Morgan Lowers Price Target on Baxter Intl to $60,2011-12-13 09:02:00-05:00,BAX,negative
139103.0,Synovis Life Technologies Rises 50% on Acquisition by Baxter ,2011-12-13 08:37:00-05:00,BAX,neutral
139104.0,Baxter Signs Definitive Agreement to Acquire Synovis for $28 per Share,2011-12-13 08:01:00-05:00,BAX,positive
139105.0,JP Morgan Lowers PT on Baxter International to $60,2011-12-13 06:52:00-05:00,BAX,positive
139106.0,Notable Put Options Activity in Baxter International,2011-12-07 13:40:00-05:00,BAX,neutral
139107.0,Piper Jaffray Rates Baxter Overweight; $69 PT,2011-11-30 12:09:00-05:00,BAX,negative
139108.0,UPDATE: Morgan Keegan Lowers Price Target on Baxter International to $60,2011-11-29 07:40:00-05:00,BAX,negative
139109.0,Morgan Keegan Lowers PT on Baxter International to $60,2011-11-29 06:45:00-05:00,BAX,negative
139110.0,Baxter International Hits 52-Week Low of $48.02,2011-11-23 09:33:00-05:00,BAX,negative
139111.0,UPDATE: Citi Lowers PT to $50 on Baxter International ,2011-11-18 08:18:00-05:00,BAX,negative
139112.0,Morgan Stanley Overweight on Baxter International,2011-11-18 07:44:00-05:00,BAX,negative
139113.0,"Morgan Keegan Reiterates Outperform, PT of $67 on Baxter International  ",2011-11-18 07:26:00-05:00,BAX,neutral
139114.0,Citigroup Lowers PT on Baxter International to $50,2011-11-18 06:33:00-05:00,BAX,negative
139115.0,Morgan Keegan Maintains Outperform Rating and $67 PT on Baxter International  ,2011-11-07 08:02:00-05:00,BAX,neutral
139116.0,Baxter Introduces NUMETA in Europe as the First-Ever Triple-Chamber IV Nutrition System for Preterm Newborns and Children   ,2011-11-04 07:31:00-04:00,BAX,neutral
139117.0,Baxter's Hemophilia Drug Cuts Bleeding Risk by 62% According to Study,2011-11-02 17:49:00-04:00,BAX,negative
139118.0,UPDATE: Citi Raises Price Target on Baxter International to $51,2011-10-21 09:11:00-04:00,BAX,neutral
139119.0,UPDATE: Piper Jaffray Lowers PT to $69 on Baxter International ,2011-10-21 08:24:00-04:00,BAX,negative
139120.0,Morgan Stanley Maintains Overweight Rating and $63 PT on Baxter International ,2011-10-21 08:09:00-04:00,BAX,negative
139121.0,Citigroup Raises PT on Baxter International to $51,2011-10-21 07:14:00-04:00,BAX,neutral
139122.0,Piper Jaffray Lowers PT on Baxter International to $69,2011-10-21 06:55:00-04:00,BAX,negative
139123.0,Earnings Roundup,2011-10-20 10:08:00-04:00,BAX,neutral
139124.0,UPDATE: Baxter Reports 9.7% Rise In Q3 Earnings ,2011-10-20 09:34:00-04:00,BAX,neutral
139125.0,Baxter International Inc Sees Earnings Rise,2011-10-20 09:09:00-04:00,BAX,neutral
139126.0,Baxter International Reports Q3 EPS $1.09 vs $1.08 Est; Revenues $3.48B vs $3.41B Est		,2011-10-20 08:46:00-04:00,BAX,neutral
139127.0,"Earnings Preview: Baxter International's EPS, Revenue Expected to Rise",2011-10-17 11:32:00-04:00,BAX,neutral
139128.0,Aetna Says Policy on Baxter and Grifols Drugs Haven't Changed,2011-10-13 12:34:00-04:00,BAX,neutral
139129.0,Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease   ,2011-10-13 09:02:00-04:00,BAX,neutral
139130.0,Teva and Baxter Must Pay $120M in Damages Over Propofol,2011-10-12 17:18:00-04:00,BAX,negative
139131.0,Volatility Crush  10-12-2011,2011-10-12 15:33:00-04:00,BAX,negative
139132.0,"Financial Breakfast: Morning News Summary for September 27, 2011",2011-09-27 07:50:00-04:00,BAX,neutral
139133.0,JP Morgan Upgrades Baxter International to Overweight,2011-09-27 06:11:00-04:00,BAX,neutral
139134.0,Morgan Keegan Maintains Outperform on Baxter International,2011-09-12 07:42:00-04:00,BAX,neutral
139135.0,U of Colorado Opens Cord Blood Bank: What About Cord Blood Stocks,2011-09-07 13:01:00-04:00,BAX,neutral
139136.0,Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures   ,2011-08-31 08:31:00-04:00,BAX,positive
139137.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue,2011-08-29 01:33:00-04:00,BAX,positive
139138.0,Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue,2011-08-29 01:31:00-04:00,BAX,positive
139139.0,Market Update,2011-08-25 09:32:00-04:00,BAX,neutral
139140.0,Baxter to Acquire Privately Held Baxa Corporation   ,2011-08-25 07:30:00-04:00,BAX,neutral
139141.0,Baxter International Crosses Above 200-Day MA at $54.14,2011-08-15 10:21:00-04:00,BAX,neutral
139142.0,FDA Offical Will Speak Today on Device Report to Industry Lawyers,2011-08-04 11:11:00-04:00,BAX,neutral
139143.0,Piper Jaffray Overweight On Baxter International ,2011-08-02 07:33:00-04:00,BAX,negative
139144.0,Hearing Supreme Court Asked to Overturn Obama's Health Care Reform,2011-07-27 15:19:00-04:00,BAX,positive
139145.0,Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency   ,2011-07-25 08:31:00-04:00,BAX,positive
139146.0,J.P. Morgan Raises EPS Forecast On Baxter Intl,2011-07-22 09:25:00-04:00,BAX,neutral
139147.0,UPDATE: Morgan Stanley Raising Price Target On Baxter International,2011-07-22 08:28:00-04:00,BAX,neutral
139148.0,UPDATE: Morgan Stanley Raises PT on Baxter International from $58 to $63,2011-07-22 07:34:00-04:00,BAX,neutral
139149.0,JP Morgan Raises PT On Baxter International To $64,2011-07-22 06:54:00-04:00,BAX,positive
139150.0,Morgan Stanley Raises PT On Baxter International to $63,2011-07-22 05:58:00-04:00,BAX,neutral
139151.0,"News Summary for July 20, 2011",2011-07-21 07:53:00-04:00,BAX,neutral
139152.0,Baxter Intl Raises 2011 View To EPS $4.27-$4.32 vs. $4.26 Est; Had Seen $4.20-$4.28,2011-07-21 07:04:00-04:00,BAX,neutral
139153.0,Baxter International Reports Q2 Prelim EPS of $1.07 vs. $1.02 Est; Revenues $3.54B vs. $3.38B Est		,2011-07-21 07:02:00-04:00,BAX,neutral
139154.0,Earnings Preview: Baxter International Earnings Expected to Increase Over Last Quarter,2011-07-18 14:55:00-04:00,BAX,positive
139155.0,UPDATE: Piper Jaffray Raises PT on Baxter International to $68,2011-07-18 07:23:00-04:00,BAX,neutral
139156.0,Piper Jaffray Raises PT On Baxter Int'l To $68,2011-07-18 05:59:00-04:00,BAX,neutral
139157.0,JP Morgan Comments on Trial Completion of Baxter's Alzheimer's Drug,2011-07-14 07:35:00-04:00,BAX,positive
139158.0,Morgan Stanley Provides Color on Baxter,2011-07-13 06:30:00-04:00,BAX,neutral
139159.0,"Morgan Keegan's Favorite Ideas in the Hospital Supplies Group: Baxter, Covidien, and Hill-Rom",2011-07-12 08:49:00-04:00,BAX,positive
139160.0,Monday's Put/Call Ratio Leaders,2011-07-11 12:27:00-04:00,BAX,neutral
139161.0,Market Reacts to Unemployment  07-08-2011,2011-07-08 13:27:00-04:00,BAX,negative
139162.0,Baxter and Halozyme Announce Top-Line Results of Phase III Study of HyQ in Patients with Primary Immunodeficiency   ,2011-07-08 08:39:00-04:00,BAX,neutral
139163.0,Morgan Keegan Has Outperform On Baxter International ,2011-07-08 07:38:00-04:00,BAX,neutral
139164.0,Stocks to Watch for 07/8/11: Fresh 52 Week Highs and Lows,2011-07-08 00:59:00-04:00,BAX,positive
139165.0,Baxter's Phase Two Study Suggests Use of Adult Autologous Stem Cells May Improve Cardiac Function in Angina Patients ,2011-07-07 16:17:00-04:00,BAX,positive
139166.0,Stocks to Watch for 07/7/11: Fresh 52 Week Highs and Lows,2011-07-07 00:14:00-04:00,BAX,positive
139167.0,Piper Jaffray Comments on May Data for Baxter International,2011-06-27 08:11:00-04:00,BAX,neutral
139168.0,Baxter Receives Positive Opinion for IVIG Therapy in Europe for Treatment of Multifocal Motor Neuropathy   ,2011-06-24 08:45:00-04:00,BAX,positive
139169.0,Goldman Sachs PT Changes For 5/31,2011-05-31 07:59:00-04:00,BAX,neutral
139170.0,Goldman Sachs Raises Baxter Target from $69 to $72,2011-05-31 07:28:00-04:00,BAX,neutral
139171.0,Piper Jaffray Reports On Stability Of BAX,2011-05-26 07:47:00-04:00,BAX,neutral
139172.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,BAX,positive
139173.0,Update: Morgan Keegan Raising Price Target On Baxter International Inc.,2011-05-20 07:35:00-04:00,BAX,neutral
139174.0,Morgan Keegan Raises PT On Baxter Int'l To $70,2011-05-20 05:59:00-04:00,BAX,neutral
139175.0,Bank of America Raises PT on Baxter International To $67,2011-05-19 07:46:00-04:00,BAX,neutral
139176.0,"CEOWORLD stock picks that will outperform the S&P 500- BRK-B, SAM, LUK, NYB, SYY, BAX, LVB, RSO, UAN…",2011-05-16 05:35:00-04:00,BAX,neutral
139177.0,Piper Jaffray Reiterates Overweight Rating On BAX,2011-05-02 10:01:00-04:00,BAX,negative
139178.0,"Earnings Preview For Becton, Dickinson And Company (BDX, BAX, BCR)",2011-04-25 11:17:00-04:00,BAX,neutral
139179.0,Piper Jaffray Comments On Baxter Q1 Results,2011-04-21 09:39:00-04:00,BAX,neutral
139180.0,Baxter Reports Q1 EPS $0.98 vs. $0.93 Estimate (BAX),2011-04-21 07:00:00-04:00,BAX,neutral
139181.0,"Ligand Partner Prism Pharmaceuticals To Be Acquired By Baxter (LGND, BAX)",2011-04-20 08:01:00-04:00,BAX,neutral
139182.0,"Who Will Benefit From Revaluation Of Yuan? (BDC, ARW, APH, APP, TBL, MDT, STE, BAX, NEWP)",2011-04-19 12:26:00-04:00,BAX,positive
139183.0,"Baxter Announces the Acquisition of Prism Pharmaceuticals, Includes Up To $338M Consideration (BAX)",2011-04-18 08:34:00-04:00,BAX,neutral
139184.0,Defense is the Best Offense  04-14-2011,2011-04-14 18:35:00-04:00,BAX,positive
139185.0,Options Brief: Baxter International Inc. (BAX),2011-04-14 13:24:00-04:00,BAX,neutral
139186.0,Baxter Presents Phase III Clinical Study Data Assessing the Use of ARTISS for Facelift Surgery   ,2011-04-11 08:31:00-04:00,BAX,neutral
139187.0,UPDATE: Morgan Keegan Raising Price Target On Baxter (BAX),2011-04-04 07:53:00-04:00,BAX,neutral
139188.0,Baxter International Plunging (BAX) ,2011-03-30 13:53:00-04:00,BAX,neutral
139189.0,Piper Jaffray Maintains OW Rating On BAX,2011-03-25 07:47:00-04:00,BAX,neutral
139190.0,J.P. Morgan Comments On Baxter Presentations At AAAAI,2011-03-23 06:58:00-04:00,BAX,neutral
139191.0,Goldman Sachs Raises BAX PT To $62,2011-03-18 09:06:00-04:00,BAX,neutral
139192.0,Morgan Keegan Comments On FDA Safety Alert On CSL's Vivaglobin For Baxter International,2011-03-14 07:20:00-04:00,BAX,positive
139193.0,"Piper Jaffray Reiterates OW Rating, $63 PT On BAX",2011-02-28 08:04:00-05:00,BAX,neutral
139194.0,"Fast Money Picks For February 22nd (BAX, AMD, PBR, PAAS, SLW)",2011-02-18 20:08:00-05:00,BAX,neutral
139195.0,"Morgan Keegan Maintains Outperform Rating, $60 PT On BAX",2011-02-15 08:24:00-05:00,BAX,neutral
139196.0,"Fast Money Picks For February 14th (VZ, RJF, AMD, BAX, TTM)",2011-02-11 20:03:00-05:00,BAX,neutral
139197.0,Oil Under Pressure  02-07-2011,2011-02-07 14:50:00-05:00,BAX,negative
139198.0,Options Brief: Baxter International Inc. (BAX),2011-02-07 10:47:00-05:00,BAX,neutral
139199.0,Morgan Keegan Comments On Baxter International Following In-Line Earnings Results,2011-01-28 09:02:00-05:00,BAX,neutral
139200.0,Deutsche Bank Reiterates Buy On Baxter International (BAX),2011-01-28 07:35:00-05:00,BAX,neutral
139201.0,Piper Jaffray Reiterates Overweight on Baxter (BAX),2011-01-28 07:20:00-05:00,BAX,negative
139202.0,"Baxter Beats on EPS, Net Dips - Analyst Blog",2011-01-27 14:01:00-05:00,BAX,neutral
139203.0,"Baxter Beats on EPS, Net Dips - Analyst Blog",2011-01-27 13:30:00-05:00,BAX,neutral
139204.0,Deutsche Bank Comments on Baxter International's 2011 Guidance (BAX),2011-01-27 09:55:00-05:00,BAX,neutral
139205.0,Baxter Reports Q4 EPS of $1.11,2011-01-27 07:08:00-05:00,BAX,neutral
139206.0,Goldman Sachs Suggests Buying Call Spreads on BAX,2011-01-26 09:42:00-05:00,BAX,neutral
139207.0,Earnings Preview: Baxter  - Analyst Blog,2011-01-25 08:31:00-05:00,BAX,neutral
139208.0,Earnings Preview: Baxter  - Analyst Blog,2011-01-25 08:15:00-05:00,BAX,neutral
139209.0,Goldman Suggests Buying Call Spreads on Baxter (BAX),2011-01-20 09:22:00-05:00,BAX,neutral
139210.0,Morgan Keegan Anticipates In-Line 4Q Results For BAX,2011-01-13 08:30:00-05:00,BAX,negative
139211.0,"Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Dividend Yield (BAX, BDX, COV, ACL)",2011-01-10 04:54:00-05:00,BAX,positive
139212.0,Becton Files for New Herpes Tests - Analyst Blog,2011-01-04 11:03:00-05:00,BAX,neutral
139213.0,Becton Files for New Herpes Tests - Analyst Blog,2011-01-04 10:45:00-05:00,BAX,neutral
139214.0,CareFusion Unveils New Ventilator - Analyst Blog,2010-12-21 12:03:00-05:00,BAX,neutral
139215.0,CareFusion Unveils New Ventilator - Analyst Blog,2010-12-21 11:45:00-05:00,BAX,neutral
139216.0,Fund Finds Growth Comes in All Sizes,2010-12-15 10:08:00-05:00,BAX,positive
139217.0,Morgan Keegan Has Outperform On Baxter International (BAX),2010-12-14 09:05:00-05:00,BAX,neutral
139218.0,Baxter Announces Share Repurchase Authorization of $2.5 Billion ,2010-12-13 16:07:00-05:00,BAX,positive
139219.0,Goldman Sees Upside In Baxter's Earnings,2010-12-09 08:11:00-05:00,BAX,neutral
139220.0,Piper Remains Overweight On Baxter,2010-12-09 08:04:00-05:00,BAX,negative
139221.0,Becton Dickinson Raises Dividend - Analyst Blog,2010-11-26 09:00:00-05:00,BAX,neutral
139222.0,Becton Dickinson Raises Dividend - Analyst Blog,2010-11-26 03:31:00-05:00,BAX,neutral
139223.0,Baxter Buying Hemophilia Assets - Analyst Blog,2010-11-22 16:22:00-05:00,BAX,positive
139224.0,11 Stocks Boosting Dividend Payouts,2010-11-22 12:28:00-05:00,BAX,positive
139225.0,Baxter Buying Hemophilia Assets - Analyst Blog,2010-11-22 10:30:00-05:00,BAX,positive
139226.0,Goldman Sachs Revises Numbers On Baxter International,2010-11-22 09:12:00-05:00,BAX,neutral
139227.0,Baxter Acquires Hemophilia-Related Assets of Archemix ,2010-11-19 09:03:00-05:00,BAX,positive
139228.0,Morgan Keegan Responds To Investor Questions Regarding BAX Sigma Pump,2010-11-16 08:29:00-05:00,BAX,neutral
139229.0,Baxter International Maintains Outperform Rating,2010-11-15 09:03:00-05:00,BAX,neutral
139230.0,Baxter Int'l Boosts Dividend - Analyst Blog,2010-11-10 18:33:00-05:00,BAX,positive
139231.0,Baxter Raises Quarterly Dividend of $.29,2010-11-09 09:19:00-05:00,BAX,neutral
139232.0,"There's Still Upside Left For Baxter International, Deutsche Bank Reports",2010-11-05 08:51:00-04:00,BAX,neutral
139233.0,China & Grain Markets  10-28-2010,2010-10-28 15:18:00-04:00,BAX,neutral
139234.0,Baxter Introduces GLASSIA - Analyst Blog,2010-10-27 17:00:00-04:00,BAX,neutral
139235.0,Baxter Beats Estimates - Analyst Blog,2010-10-21 13:33:00-04:00,BAX,neutral
139236.0,"Earnings Scheduled For October 21 (MCD, CAT, T, LLY, CS, UAL, BAX, NVS, UNP, UPS, BBT, PM, RAI, CTXS, SNDK, JBLU, AXP, TRV, LUV, AMZN, STI, HSY, XRX, CB)",2010-10-21 04:27:00-04:00,BAX,neutral
139237.0,Earnings Preview: Baxter - Analyst Blog,2010-10-20 18:54:00-04:00,BAX,neutral
139238.0,Baxter International Inc. - Growth & Income,2010-10-19 08:06:00-04:00,BAX,positive
139239.0,JP Morgan Updates Model On BAX,2010-10-18 08:41:00-04:00,BAX,positive
139240.0,Peter Hellman Elected to Goodyear Board,2010-10-05 09:15:00-04:00,BAX,neutral
139241.0,Morgan Keegan Reiterates Outperform On BAX,2010-10-04 06:59:00-04:00,BAX,neutral
139242.0,Complications For BAX,2010-09-29 12:43:00-04:00,BAX,neutral
139243.0,Baxter's Growth Sustainable Through 2013/2014 According To Goldman,2010-09-29 09:07:00-04:00,BAX,positive
139244.0,Deutsche Bank Discusses Hospital Trends,2010-09-27 09:24:00-04:00,BAX,neutral
139245.0,Piper Jaffray Sees Significant Upside In Baxter International (BAX),2010-09-27 07:21:00-04:00,BAX,positive
139246.0,Morgan Keegan Maintains Outperform On Baxter (BAX),2010-09-27 06:52:00-04:00,BAX,neutral
139247.0,Data Good -- SPY Near Resistance  09-24-2010,2010-09-24 15:15:00-04:00,BAX,positive
139248.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:34:00-04:00,BAX,neutral
139249.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:33:00-04:00,BAX,neutral
139250.0,"Benzinga's Top Downgrades (CRH, NEP, BAX, LVS) ",2010-09-08 07:45:00-04:00,BAX,positive
139251.0,"Citi Downgrades Baxter, Cuts Price Target (BAX)",2010-09-08 06:59:00-04:00,BAX,negative
139252.0,Corporate Incubators and New Business Creation,2010-09-01 05:36:00-04:00,BAX,positive
139253.0,Top Cord Blood Stocks,2010-08-26 10:53:00-04:00,BAX,positive
139254.0,Piper Jaffray is 'Aggressive Buyer' of Baxter Int'l (BAX),2010-08-18 14:23:00-04:00,BAX,negative
139255.0,Baxter Int'l Sees Higher Pump Sales vs. Leases,2010-08-11 11:02:00-04:00,BAX,neutral
139256.0,"Fast Money Picks For August 11th (SLV, MTL, BAX, PM, AKAM)",2010-08-10 19:03:00-04:00,BAX,neutral
139257.0,Market Pulls Back on China News  08-10-2010,2010-08-10 14:40:00-04:00,BAX,neutral
139258.0,Diagonal Call Spread Trade on Baxter (BAX),2010-08-10 12:24:00-04:00,BAX,neutral
139259.0,"Fast Money Picks For August 6th (VIX, BAX, HPQ, DD)",2010-08-04 18:27:00-04:00,BAX,neutral
139260.0,Baxter International Inc. Receives Outperformer Rating (BAX) ,2010-08-02 16:06:00-04:00,BAX,neutral
139261.0,Piper Jaffray Overweight On Baxter (BAX),2010-07-26 10:31:00-04:00,BAX,negative
139262.0,"News Summary (SNDK, AMZN, MCD, WMT, BAX)",2010-07-23 11:12:00-04:00,BAX,neutral
139263.0,Rough Outlook for Plasma Protein Market,2010-07-15 11:57:00-04:00,BAX,neutral
139264.0,Goldman Sachs Reiterates Neutral Rating on Baxter International (BAX),2010-06-16 09:57:00-04:00,BAX,neutral
139265.0,US Markets Follow Europe's Gains  06-09-2010,2010-06-09 14:38:00-04:00,BAX,positive
139266.0,Watch SPX Key Support 1050  06-08-2010,2010-06-08 16:07:00-04:00,BAX,positive
139267.0,Drug Recall to Negatively Impact Halozyme: Retains ‘Outperform’ Rating At Oppenheimer (HALO) ,2010-06-07 12:12:00-04:00,BAX,neutral
139268.0,Piper Jaffray Reiterates Overweight Rating on Baxter International (BAX),2010-06-07 09:41:00-04:00,BAX,negative
139269.0,Morgan Keegan Reiterates Outperform Rating on Baxter International (BAX),2010-06-02 09:22:00-04:00,BAX,neutral
139270.0,"IVIG Market Update (GIFLF.PK, BAX, HAE)",2010-06-01 16:08:00-04:00,BAX,neutral
139271.0,"Mad Money Lightning Round: Jim Discusses HUN, GTE, GILD, GS, BAX, CHU, WHR, OC, QCOM",2010-05-27 09:44:00-04:00,BAX,negative
139272.0,Halozyme Announces Recall,2010-05-17 09:29:00-04:00,BAX,neutral
139273.0,Halozyme Announces Recall,2010-05-17 09:27:00-04:00,BAX,neutral
139274.0,"A Look At Lone Pine Capital's Portfolio (JPM, MON, BAX, QCOM)",2010-05-11 18:16:00-04:00,BAX,negative
139275.0,Baxter International To Recall Colleague Pumps (BAX),2010-05-04 12:30:00-04:00,BAX,neutral
139276.0,"Baxter International (BAX) Keeps Outperform Rating, Despite Recall",2010-05-04 10:00:00-04:00,BAX,neutral
139277.0,"Follow the Leader: Goldman Sachs’ Top 15 Stock Holdings (AAPL, BAX, CSCO, DG, EDMC, EEM, GS, IWM, JNJ, JPM, MSFT, ORCL, PEP, PG, SPY, XOM)",2010-04-27 16:26:00-04:00,BAX,positive
139278.0,"Benzinga’s Top Downgrades (BAX, LGF, FITB, DG, CLP)",2010-04-26 11:12:00-04:00,BAX,positive
139279.0,"Company News for April 26, 2010 - Corporate Summary",2010-04-26 09:30:00-04:00,BAX,neutral
139280.0,"Benzinga's After Hours Gainers (JCI, BAX, GT, WMB)",2010-04-23 17:21:00-04:00,BAX,positive
139281.0,"Stock Market News for April 23, 2010 - Market News",2010-04-23 10:00:00-04:00,BAX,neutral
139282.0,Baxter International (BAX) Shares Plunge 15%,2010-04-22 12:19:00-04:00,BAX,positive
139283.0,"Stock Market News for April 22, 2010 - Market News",2010-04-22 09:30:00-04:00,BAX,neutral
139284.0,"Despite Positive Data By Baxter, Questions Remain Regarding IVIG In Alzheimer's",2010-04-14 15:50:00-04:00,BAX,negative
139285.0,FDA Approves Patch To Be Distributed By Baxter International (BAX),2010-04-06 11:34:00-04:00,BAX,positive
139286.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,BAX,positive
139287.0,"Medical Devices Industry Update (BAX, BCR, COO, MASI, HAE)",2010-03-23 12:33:00-04:00,BAX,neutral
139288.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,BAX,neutral
139289.0,This Healthcare ETF (XLV) Is Seeing Above Average Call Buying,2010-03-17 13:42:00-04:00,BAX,neutral
139290.0,"Top 10 Picks For Playing The Market: CNBC (RHI, VPRT, TRLG, GSIC, CSCO)",2010-03-10 07:05:00-05:00,BAX,positive
139291.0,"Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL)",2010-02-22 17:22:00-05:00,BAX,neutral
139292.0,Increased Confidence In BAX 2010 Estimates,2010-02-22 11:19:00-05:00,BAX,positive
139293.0,Baxter International Downgraded to Hold (BAX),2010-01-19 13:28:00-05:00,BAX,neutral
139294.0,"New Products And Scale Expected To Drive Med Tech This Year  (MDT, EW, COV, SYK, BAX, NSPH)",2010-01-08 12:14:00-05:00,BAX,neutral
139295.0,Baxter (BAX) Vaccine Could Rake In Profits Of $30 Million For Next Quarter,2009-12-11 13:45:00-05:00,BAX,positive
139296.0,"Top S&P 500 Laggards (JNPR, BAX, S, LUV)",2009-11-12 13:07:00-05:00,BAX,positive
139297.0,"SVA Rallies As H1N1 Influenza Awakens (SVA, BCRX, BAX, HEB)",2009-10-09 17:30:00-04:00,BAX,neutral
